UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB


(Mark One)

|X|   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE ACT
      OF 1934

                For the quarterly period ended September 30, 2006

|_|   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

              For the transition period from________ to ___________

                         Commission File No. 333-105840


                         MEDICAL MEDIA TELEVISION, INC.
        (Exact Name of Small Business Issuer as Specified in Its Charter)


           Florida                                        59-3645932
           -------                                        ----------
(State or Other Jurisdiction of                         (I.R.S. Employer
Incorporation or Organization)                         Identification No.)

                           8406 Benjamin Road, Suite C
                              Tampa, Florida 33634
                    (Address of Principal Executive Offices)


                                 (813) 888-7330
                           (Issuer's Telephone Number)


--------------------------------------------------------------------------------
              (Former Name, Former Address and Former Fiscal Year,
                         if Changed Since Last Report)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days.
                                    Yes ? No

Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).

                                 Yes |X| No |_|


The number of shares outstanding of the Registrant's common stock as of November
7, 2006 was 21,117,136.


Transitional Small Business Disclosure Format:

                                 Yes |_| No |X|

<PAGE>

PART I - FINANCIAL INFORMATION

Item 1.     Financial Statements.

In the opinion of management,  the accompanying unaudited consolidated financial
statements included in this Form 10-QSB reflect all adjustments (consisting only
of normal recurring  accruals)  necessary for a fair presentation of the results
of  operations  for the periods  presented.  The results of  operations  for the
periods  presented are not necessarily  indicative of the results to be expected
for the full year.


Accountants' Review Report                                                     3


Consolidated Balance Sheets as of September 30, 2006
  and December 31, 2005                                                        4


Consolidated Statements of Operations for the three and
nine months ended September 30, 2006 and 2005, and from
inception (October 2, 1989) through September 30, 2006                         5


Consolidated Statements of Changes in Stockholders' Equity from
inception (October 2, 1989) through September 30, 2006                         6


Consolidated Statements of Cash Flows for the three and nine
months ended September 30, 2006 and 2005, and from inception
(October 2, 1989) through September 30, 2006                                   7


Notes to the Consolidated Financial Statements                              8-21


                                       2
<PAGE>

                         BAUMANN, RAYMONDO & COMPANY PA
                         405 North Reo Street, Suite 200
                              Tampa, Florida 33609
                                 (813) 288-8826

             Report of Independent Registered Public Accounting Firm

Board of Directors
Medical Media Television, Inc.
Tampa, Florida

We have reviewed the  accompanying  consolidated  balance sheet of Medical Media
Television,  Inc.  as of  September  30,  2006,  and  the  related  consolidated
statements  of  operations,  stockholders'  equity  and cash flows for the three
month  periods  then ended.  These  consolidated  financial  statements  are the
responsibility of the Company's management.

We conducted our reviews in accordance  with the standards of the Public Company
Accounting  Oversight  Board  (United  States).  A review of  interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with the  standards  of the  Public  Company  Accounting  Oversight  Board,  the
objective  of which is the  expression  of an opinion  regarding  the  financial
statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should
be made to such consolidated  financial  statements for them to be in conformity
with U.S. generally accepted accounting principles.

As discussed in Note A, the Company has been in the development  stage since its
inception on October 2, 1989.  Realization  of a major  portion of its assets is
dependent on the Company's  ability to meet its future  financing  requirements,
and the success of its future operations.  These factors raise substantial doubt
about the  Company's  ability to  continue  as a going  concern.  The  financial
statements do not include any adjustments  that might result from the outcome of
this uncertainty.


/s/ Baumann, Raymondo & Company PA
----------------------------------
BAUMANN, RAYMONDO & COMPANY PA
November 17, 2006


                                       3
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                           CONSOLIDATED BALANCE SHEET

<TABLE>
<CAPTION>
                                                                                     September 30,      December 31,
                                                                                         2006              2005
                                     ASSETS                                            Unaudited          Audited
                                                                                      -----------       -----------
<S>                                                                                   <C>               <C>
Current assets:
    Cash                                                                              $    37,092       $    75,248
    Accounts receivable                                                                    60,285                --
    Prepaid expenses and other current assets                                             106,421            36,010
                                                                                      -----------       -----------
         Total current assets                                                             203,798           111,258
                                                                                      -----------       -----------

Fixed assets:
    Computer equipment                                                                     18,473            19,585
    Leasehold improvements                                                                  6,196             6,196
                                                                                      -----------       -----------
                                                                                           24,669            25,781
    Less accumulated depreciation                                                         (15,918)          (11,180)
                                                                                      -----------       -----------
                                                                                            8,751            14,601
                                                                                      -----------       -----------

Other assets:
    Goodwill                                                                            1,271,037         1,271,037
    Intangible assets                                                                     240,625           300,000
    Security deposits                                                                       7,596             7,596
                                                                                      -----------       -----------
         Total other assets                                                             1,519,258         1,578,633
                                                                                      -----------       -----------

         Total assets                                                                 $ 1,731,807       $ 1,704,492
                                                                                      ===========       ===========

                      LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities:
    Accounts payable                                                                  $   326,237       $   530,175
    Accrued expenses and other current liabilities                                        797,482           512,899
    Deferred revenue                                                                       29,485            22,485
    Notes payable to stockholders                                                       2,141,999         1,496,437
                                                                                      -----------       -----------
         Total current liabilities                                                      3,295,203         2,561,996
                                                                                      -----------       -----------

Long-term liabilities
    Note payable to stockholder                                                         1,578,751           250,000
    Deferred revenue                                                                        3,786            17,985
                                                                                      -----------       -----------
         Total long-term liabilities                                                    1,582,537           267,985
                                                                                      -----------       -----------

         Total liabilities                                                              4,877,740         2,829,981
                                                                                      -----------       -----------

    Stockholders' deficit:
       Preferred stock - no par value; 25,000,000 shares authorized; 1,682,044
         Series A Zero Coupon, shares issued and outstanding, 2,612,329 Series B
         Zero Coupon, shares issued and outstanding,
         and 21,269 Series C Zero Coupon, shares issued and outstanding                 4,315,642         4,303,000
       Common stock - par value $.0005; 100,000,000 shares authorized;
         21,117,136 and 20,725,104 shares issued and outstanding at
         June 30, 2006 and December 31, 2005 respectively                                  10,558            10,363
       Additional paid-in capital                                                       1,220,830         1,098,438
       Accumulated deficit during development stage                                    (8,692,963)       (6,537,290)
                                                                                      -----------       -----------
          Total stockholders' deficit                                                  (3,145,933)       (1,125,489)
                                                                                      -----------       -----------

          Total liabilities and stockholders' deficit                                 $ 1,731,807       $ 1,704,492
                                                                                      ===========       ===========
</TABLE>

               The accompanying footnotes are an integral part of
                    these consolidated financial statements.


                                       4
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                 UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
         FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2006 AND 2005
             FROM INCEPTION (OCTOBER 2, 1989) to SEPTEMBER 30, 2006

<TABLE>
<CAPTION>
                                                      September 30, 2006                 September 30, 2005
                                               ------------------------------      ------------------------------         From
                                              For the Three     For the Nine      For the Three      For the Nine      Inception to
                                               Months Then       Months Then        Months Then      Months Then      September 30,
                                                  Ended             Ended               Ended           Ended             2006
                                               ------------      ------------      ------------      ------------      ------------
<S>                                            <C>               <C>               <C>               <C>               <C>
Revenues, net                                  $    117,723      $    301,896      $     63,547      $    112,858      $    502,428

Cost of revenues                                      8,924            58,583             8,612            29,492           102,314
                                               ------------      ------------      ------------      ------------      ------------

Gross profit                                        108,799           243,313            54,935            83,366           400,114
                                               ------------      ------------      ------------      ------------      ------------

Operating expenses:
    DVD production costs                             78,234           214,268            32,447           109,570           738,334
    General and administration                      319,171           929,547           171,950           586,417         4,198,207
    Sales and marketing                             235,490           854,224           160,410           351,437         2,685,910
    Depreciation and amortization                    21,404            64,645             1,663             4,449           220,383
                                               ------------      ------------      ------------      ------------      ------------
         Total operating expense                    654,299         2,062,684           366,470         1,051,873         7,842,834
                                               ------------      ------------      ------------      ------------      ------------

Operating loss                                     (545,500)       (1,819,371)         (311,535)         (968,507)       (7,442,720)
                                               ------------      ------------      ------------      ------------      ------------

Other income and (expense)
    Interest expense                               (130,290)         (335,242)          (29,294)         (334,367)       (1,257,312)
    Disposal of fixed assets                         (1,723)           (1,723)              105                --            (1,723)
    Interest income                                      --               174                --               254             2,039
    Other income                                         --               489                --               951             2,928
    Gain on sale of subsidiary                           --                --                --                 0             2,421
                                               ------------      ------------      ------------      ------------      ------------
         Total other income (expense)              (132,013)         (336,302)          (29,189)         (333,162)       (1,251,647)
                                               ------------      ------------      ------------      ------------      ------------

Loss before extraordinary items                    (677,513)       (2,155,673)         (340,724)       (1,301,669)       (8,694,367)

    Gain on extinguishment of debt                       --                --                --                --             1,404
                                               ------------      ------------      ------------      ------------      ------------

Loss before taxes                                  (677,513)       (2,155,673)         (340,724)       (1,301,669)       (8,692,963)

    Provision for income taxes                           --                --                --                --                --
                                               ------------      ------------      ------------      ------------      ------------

Net loss                                       $   (677,513)     $ (2,155,673)     $   (340,724)     $ (1,301,669)     $ (8,692,963)
                                               ============      ============      ============      ============      ============

Net loss per share, basic and diluted                ($0.03)           ($0.10)           ($0.26)           ($0.99)           ($5.42)
                                               ============      ============      ============      ============      ============

Weighted average shares, basic and diluted       21,117,136        21,069,984         1,309,478         1,309,337         1,602,567
                                               ============      ============      ============      ============      ============
</TABLE>

               The accompanying footnotes are an integral part of
                    these consolidated financial statements.


                                       5
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                 CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
     FOR PERIOD FROM INCEPTION (OCTOBER 2, 1989) THROUGH SEPTEMBER 30, 2006

<TABLE>
<CAPTION>
                                                Preferred Stock                 Common Stock            Additional
                                           ---------------------------   ---------------------------     Paid-in       Subscription
                                              Shares        Amount         Shares          Amount        Capital        Receivable
                                           ------------   ------------   ------------   ------------   ------------    ------------
<S>                                        <C>            <C>            <C>            <C>            <C>             <C>
Issuance of $0.01 par value common
  shares to an individual for a note                 --   $         --          1,000   $        100   $      1,900    $     (2,000)
Payment of subscription receivable                   --             --             --             --             --           1,885
Stock split 2,000:1 and change par                   --             --             --             --             --              --
  value from $0.01 to $0.0005                        --             --      1,999,000            900           (900)             --
                                           ------------   ------------   ------------   ------------   ------------    ------------
Balance, December 31, 1996                           --             --      2,000,000          1,000          1,000            (115)

Repurchase of shares                                 --             --             --             --             --              --
Issuance of common stock                             --             --      2,476,000          1,238          3,762          (5,000)
                                           ------------   ------------   ------------   ------------   ------------    ------------
Balance, December 31, 1997                           --             --      4,476,000          2,238          4,762          (5,115)

Net loss                                             --             --             --             --             --              --
                                           ------------   ------------   ------------   ------------   ------------    ------------
Balance, December 31, 1998                           --             --      4,476,000          2,238          4,762          (5,115)
                                           ------------   ------------   ------------   ------------   ------------    ------------
Balance, December 31, 1999                           --             --      4,476,000          2,238          4,762          (5,115)

Shares issued in connection
  with merger with Y2K Recording, Inc.               --             --      1,025,000            513             --              --
Net income                                           --             --             --             --             --              --
                                           ------------   ------------   ------------   ------------   ------------    ------------
Balance, December 31, 2000                           --             --      5,501,000          2,751          4,762          (5,115)

Shares issued in connection
  with merger with Savage Mojo, Inc.                 --             --      8,000,000          4,000             --              --
Shares issued for services                           --             --         10,000              5            995              --
Contributed capital                                  --             --             --             --          5,672              --
Net loss                                             --             --             --             --             --              --
                                           ------------   ------------   ------------   ------------   ------------    ------------
Balance, December 31, 2001                           --             --     13,511,000          6,756         11,429          (5,115)

Series A shares sold in private placement        47,750         95,500             --             --             --              --
Retire treasury stock                                --             --     (1,725,000)          (863)        (4,137)             --
Shares issued as premium for notes                   --             --      2,939,553          1,470             --              --
Shares issued for Cohen employment
  agreement                                          --             --        748,447            374         74,471              --
Cancellation of outstanding stock
  returned by M. Klimes                              --             --     (4,000,000)        (2,000)            --              --
Shares issued for services                           --             --        312,000            156         31,044              --
Payment of subscription receivable                   --             --             --             --             --           5,000
Write off of subscription receivable                 --             --             --             --             --             115
Net loss                                             --             --             --             --             --              --
                                           ------------   ------------   ------------   ------------   ------------    ------------
Balance, December 31, 2002                       47,750         95,500     11,786,000          5,893        112,807              --

Shares issued for services                           --             --         50,000             25          4,975              --
Series A shares sold in private placement        53,500        107,000             --             --             --              --
Series B shares sold in private placement         1,000          2,000             --             --             --              --
Net loss                                             --             --             --             --             --              --
                                           ------------   ------------   ------------   ------------   ------------    ------------
Balance, December 31, 2003                      102,250        204,500     11,836,000          5,918        117,782              --

Conversion of Series A to common               (101,250)      (202,500)       525,959            263        202,237              --
Cancellation and refund of Series B              (1,000)        (2,000)            --             --             --              --
Shares issued for services                           --             --        372,583            186        101,828              --
Shares issued for debt                               --             --        357,143            179        249,821              --
Net loss                                             --             --             --             --             --              --
                                           ------------   ------------   ------------   ------------   ------------    ------------
Balance, December 31, 2004                           --             --     13,091,685          6,546        671,668              --

Effects of 30:1 reverse stock split                  --             --    (12,654,986)        (6,327)         6,327              --
Issuance of dividend shares                          --             --        872,779            436           (436)             --
Conversion of debt to preferred               4,303,000      4,303,000             --             --             --              --
Acquisition of African American
  Medical Network, Inc.                              --             --     19,415,626          9,708        420,879              --
Net loss                                             --             --             --             --             --              --
                                           ------------   ------------   ------------   ------------   ------------    ------------
Balance, December 31, 2005                    4,303,000      4,303,000     20,725,104         10,363      1,098,438              --

Shares issued for services                           --             --        246,195            122         98,355              --
Warrants exercised                                   --             --        145,837             73         24,037              --
Conversion of debt to preferred                  12,642         12,642             --             --             --              --
Net loss                                             --             --             --             --             --              --
                                           ------------   ------------   ------------   ------------   ------------    ------------

Balance, September 30, 2006                   4,315,642   $  4,315,642     21,117,136   $     10,558   $  1,220,830    $         --
                                           ============   ============   ============   ============   ============    ============

<CAPTION>
                                              Accumulated
                                                Deficit
                                                during             Treasury Stock
                                              Development    ---------------------------
                                                 Stage          Shares         Amount         Total
                                              ------------   ------------   ------------   ------------
<S>                                           <C>            <C>            <C>            <C>
Issuance of $0.01 par value common
  shares to an individual for a note          $         --   $         --   $         --   $         --
Payment of subscription receivable                      --             --             --          1,885
Stock split 2,000:1 and change par                      --             --             --             --
  value from $0.01 to $0.0005                           --             --             --             --
                                              ------------   ------------   ------------   ------------
Balance, December 31, 1996                              --             --             --          1,885

Repurchase of shares                                    --     (1,725,000)        (5,000)        (5,000)
Issuance of common stock                                --             --             --             --
                                              ------------   ------------   ------------   ------------
Balance, December 31, 1997                              --     (1,725,000)        (5,000)        (3,115)

Net loss                                            (2,867)            --             --         (2,867)
                                              ------------   ------------   ------------   ------------
Balance, December 31, 1998                          (2,867)    (1,725,000)        (5,000)        (5,982)
                                              ------------   ------------   ------------   ------------
Balance, December 31, 1999                          (2,867)    (1,725,000)        (5,000)        (5,982)

Shares issued in connection
  with merger with Y2K Recording, Inc.                  --             --             --            513
Net income                                             434             --             --            434
                                              ------------   ------------   ------------   ------------
Balance, December 31, 2000                          (2,433)    (1,725,000)        (5,000)        (5,035)

Shares issued in connection
  with merger with Savage Mojo, Inc.                    --             --             --          4,000
Shares issued for services                              --             --             --          1,000
Contributed capital                                     --             --             --          5,672
Net loss                                           (57,151)            --             --        (57,151)
                                              ------------   ------------   ------------   ------------
Balance, December 31, 2001                         (59,584)    (1,725,000)        (5,000)       (51,514)

Series A shares sold in private placement               --             --             --         95,500
Retire treasury stock                                   --      1,725,000          5,000             --
Shares issued as premium for notes                      --             --             --          1,470
Shares issued for Cohen employment
  agreement                                             --             --             --         74,845
Cancellation of outstanding stock
  returned by M. Klimes                                 --             --             --         (2,000)
Shares issued for services                              --             --             --         31,200
Payment of subscription receivable                      --             --             --          5,000
Write off of subscription receivable                    --             --             --            115
Net loss                                          (498,888)            --             --       (498,888)
                                              ------------   ------------   ------------   ------------
Balance, December 31, 2002                        (558,472)            --             --       (344,272)

Shares issued for services                              --             --             --          5,000
Series A shares sold in private placement               --             --             --        107,000
Series B shares sold in private placement               --             --             --          2,000
Net loss                                        (1,825,313)            --             --     (1,825,313)
                                              ------------   ------------   ------------   ------------
Balance, December 31, 2003                      (2,383,785)            --             --     (2,055,585)

Conversion of Series A to common                        --             --             --             --
Cancellation and refund of Series B                     --             --             --         (2,000)
Shares issued for services                              --             --             --        102,014
Shares issued for debt                                  --             --             --        250,000
Net loss                                        (2,188,203)            --             --     (2,188,203)
                                              ------------   ------------   ------------   ------------
Balance, December 31, 2004                      (4,571,988)            --             --     (3,893,774)

Effects of 30:1 reverse stock split                     --             --             --             --
Issuance of dividend shares                             --             --             --             --
Conversion of debt to preferred                         --             --             --      4,303,000
Acquisition of African American
  Medical Network, Inc.                                 --             --             --        430,587
Net loss                                        (1,965,302)            --             --     (1,965,302)
                                              ------------   ------------   ------------   ------------
Balance, December 31, 2005                      (6,537,290)            --             --     (1,125,489)

Shares issued for services                              --             --             --         98,477
Warrants exercised                                      --             --             --         24,110
Conversion of debt to preferred                         --             --             --         12,642
Net loss                                        (2,155,673)            --             --     (2,155,673)
                                              ------------   ------------   ------------   ------------

Balance, September 30, 2006                   $ (8,692,963)  $         --   $         --   $ (3,145,933)
                                              ============   ============   ============   ============
</TABLE>

               The accompanying footnotes are an integral part of
                    these consolidated financial statements.


                                       6
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                 UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
              FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2006 AND 2005
             FROM INCEPTION (OCTOBER 2, 1989) TO SEPTEMBER 30, 2006

<TABLE>
<CAPTION>
                                                                                                                  From
                                                                            Nine Months Ended                 Inception to
                                                                   --------------------------------------     September 30,
                                                                   September 30, 2006   September 30, 2005         2006
                                                                   ------------------   ------------------     -----------
<S>                                                                    <C>                 <C>                 <C>
CASH FLOWS FROM OPERATING ACTIVITES
  Net loss                                                             $(2,155,673)        $(1,301,669)        $(8,692,963)
     Adjustments to reconcile net loss to net cash flows from
        operating activities:
          Depreciation and amortization expense                             64,112               4,449              82,924
          Cash from acquisition of African American Medical
             Network, Inc.                                                      --                  --               2,104
          Gain on sale of subsidiary                                            --                  --              (2,421)
          Gain on extinguishment of debt                                        --                  --              (1,404)
          Common stock issued for services                                  98,478                  --             306,537
          Bad debt expense                                                      --             (10,000)                 --
          Changes in assets and liabilities:
             Accounts receivable                                           (60,285)             19,470             (60,285)
             Other current receivables                                         150              (8,714)                150
             Prepaid expenses                                              (70,562)             34,233            (106,558)
             Other receivables                                                  --                  --              65,521
             Security deposits                                                  --                  --              (7,596)
             Accounts payable                                             (203,938)            218,200             (82,388)
             Accrued expenses and other current liabilities                315,027             546,976           1,415,106
                                                                       -----------         -----------         -----------

Net cash flows (used) in operating activities                           (2,012,691)           (497,055)         (7,081,273)
                                                                       -----------         -----------         -----------

CASH FLOWS FROM INVESTING ACTIVITIES
  Purchase of equipment                                                     (1,143)             (5,227)            (25,170)
  Disposal of equipment                                                      2,255                  --               2,255
                                                                       -----------         -----------         -----------

Net cash flows (used) in investing activities                                1,112              (5,227)            (22,915)
                                                                       -----------         -----------         -----------

CASH FLOWS FROM FINANCING ACTIVITIES
  Common stock issued for cash                                                  --                  --              14,185
  Common stock issued for exercise of warrants                              24,110                  --              24,110
  Preferred stock issued for cash                                               --                  --             202,500
  Proceeds from notes payable-net                                        1,949,313             500,000           6,900,485
                                                                       -----------         -----------         -----------

Net cash flows provided by financing activities                          1,973,423             500,000           7,141,280
                                                                       -----------         -----------         -----------

Increase (decrease) in cash                                                (38,156)             (2,282)             37,092
Cash, beginning of period                                                   75,248              18,793                  --
                                                                       -----------         -----------         -----------
Cash, end of period                                                    $    37,092         $    16,511         $    37,092
                                                                       ===========         ===========         ===========

               SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

Cash paid for interest                                                 $   169,780         $     1,224         $   179,245
                                                                       ===========         ===========         ===========

Acquisition of African American Medical Network, Inc.                  $        --         $        --         $ 1,571,037
                                                                       ===========         ===========         ===========

Common Stock issued for debt                                           $        --         $        --         $   250,000
                                                                       ===========         ===========         ===========

Preferred Stock issued for debt                                        $    12,642         $        --         $ 4,315,642
                                                                       ===========         ===========         ===========
</TABLE>

               The accompanying footnotes are an integral part of
                    these consolidated financial statements.

                                       7
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Medical Media Television, Inc. ("Medical Media" or the "Company";  references to
"we," "our" or "us" also mean the Company) is a Florida corporation organized on
October 2, 1989.  We are a  development  stage  company  focused on  developing,
establishing,  marketing,  and distributing educational programming on a monthly
basis to  participating  subscribers  to our  veterinary  network,  our  medical
network directed to the African American population,  and our pediatric network.
Our educational  programming is obtained  through an annual  subscription and is
funded,  in part,  by commercial  advertisers  who benefit from an effective and
convenient  advertising  medium to target  their goods and  services to consumer
patients.   Our  goal  is  to  be   recognized   as  a   leading   provider   of
advertiser-supported  medical  education  programming  for  patients and clients
within  the  place-based   media   environment  of  medical   specialty  offices
nationwide.

We  provide   advertiser-supported   patient/parent/client   medical   education
programming  within the  place-based  media  environment  of  medical  specialty
offices  nationwide.  We have  three  wholly  owned  subsidiaries:  (1)  PetCARE
Television  Network,  Inc. ("PetCARE TV"), (2) African American Medical Network,
Inc. ("African  American Medical  Network");  and (3) KidCARE Medical Television
Network,  Inc.  ("KidCARE  TV"). As discussed in more detail below,  each of our
subsidiaries targets a different consumer base.

Medical  Media  produces  monthly  DVD  magazines  that are  distributed  to the
participating subscribers of PetCARE TV and African American Medical Network. We
plan to  provide  monthly  programming  for  KidCARE TV either  through  monthly
updated DVD  magazines  or through  direct video  streaming at each  subscribing
location.  Programming is funded,  in part, by commercial  advertisers  that are
reviewed and  approved by the  advisory  boards  serving  each  subsidiary.  Our
programming is obtained through an annual  subscription with updated programming
provided directly to the subscribers.

PetCARE TV

PetCARE TV's goal is to provide  animal health and welfare  education to a large
number of  consumers of pet  products  and  services  while  serving as a unique
advertising  medium for  companies  that market  those goods and  services.  Our
educational  programming is currently aired in veterinary  practices  across the
U.S.,  Canada,  Puerto Rico, and Australia  where it is viewed by an estimated 6
million  pet owners each  month.  Each month  PetCARE TV provides an updated DVD
magazine focused on optimal  healthcare for animal  companions.  PetCARE TV also
sells an instructional  DVD to veterinarians  for them to give to their clients,
entitled "Welcome Home Your New Friend".

African American Medical  Network

African American Medical Network's goal is to provide educational programming to
doctor's offices nationwide serving African American patients, and to provide an
advertising medium for commercial advertisers to target their goods and services
to these  consumer  patients.  Our  educational  programming  currently  airs in
hundreds of physician offices across the U.S. and is targeted to the patients of
the more than  15,000  doctors  who serve the  majority  of the 35 million  U.S.
African Americans.


                                       8
<PAGE>
                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

KidCARE TV

KidCARE TV will target parent consumers in pediatric  waiting rooms  nationwide.
KidCARE  TV is not yet  operational,  but  plans to  establish  a  collaborative
interaction with the viewing audience through its short  informational  segments
developed to create  awareness about  preventative  health  measurers along with
specific  childhood  illnesses  and  issues.  These  segments  are  designed  to
stimulate  the  viewer  to  seek  further  guidance  from  their   pediatrician.
Interspersed   throughout   the   segments,   promotional   pieces  will  appear
demonstrating  related  health  care  items.  KidCARE  TV's  primary  target for
subscribership will be members of the American Academy of Pediatrics. KidCARE TV
also  sells an  instructional  DVD to  physicians  for them to give to their new
parents entitled "Welcome Home Your New Baby."

Basis of Accounting

Medical Media  maintains its financial  records and financial  statements on the
accrual basis of  accounting.  The accrual  basis of  accounting  provides for a
better matching of revenues and expenses.

Interim Information

The accompanying  unaudited  consolidated  financial statements of Medical Media
have been prepared in accordance with accounting  principles  generally accepted
in the United States of America for interim  financial  information and with the
instructions to Form 10-QSB and Rule 10-01 of Regulation  S-X. All  adjustments,
which,  in the opinion of management,  are necessary for a fair  presentation of
the financial condition and results of operations, have been included. Operating
results for the three and nine month  periods  ended  September 30, 2006 are not
necessarily  indicative  of the results that may be expected for the year ending
December 31, 2006.

Cash and Cash Equivalents

For  purposes  of the  Consolidated  Statements  of Cash  Flows,  Medical  Media
considers amounts held by financial institutions and short-term investments with
an original maturity of 90 days or less to be cash and cash equivalents.

Fiscal Year

Medical Media elected December 31 as its fiscal year.

Revenue Recognition

The Company generates revenue from three primary sources,  namely advertisers on
its  DVD  magazines  (the  "Advertisers"),   subscribers  to  its  network  (the
"Subscribers"),  and the sale of our instructional  DVDs,  Welcome Home Your New
Friend and Welcome Home Your New Baby. With regard to  Advertisers,  the Company
recognizes revenue over the periods in which the advertisers' commercials appear
on  its  DVD  magazine.  With  regard  to  Subscribers,  revenue  is  recognized
proportionately  over the length of the subscription  agreement  entered into by
the  Subscribers.  With regard to Welcome  Home Your New Friend and Welcome Home
Your New Baby, revenue is recognized in the period the DVDs are shipped.


                                       9
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Income Taxes

Medical Media  records its federal and state tax  liability in  accordance  with
Financial  Accounting  Standards  Board Statement No. 109 "Accounting for Income
Taxes".  The  deferred  taxes  payable are recorded  for  temporary  differences
between the  recognition of income and expenses for tax and financial  reporting
purposes, using current tax rates. Deferred assets and liabilities represent the
future tax  consequences of those  differences,  which will be either taxable or
deductible when the assets and liabilities are recovered or settled.

Since its  inception,  Medical Media has an  accumulated  loss of $8,675,127 for
income tax purposes,  which can be used to offset future  taxable income through
2023. The potential tax benefit of this loss is as follows:

      Future tax benefit               $ 2,602,538
      Valuation allowance               (2,602,538)
                                       -----------

      Future tax benefit               $        --
                                       ===========

As of  September  30,  2006,  the  Company  recorded a  valuation  allowance  of
$2,602,538  on the  deferred  tax  assets to reduce it to zero.  Realization  of
deferred tax assets is dependent  upon  sufficient  future taxable income during
the period that deductible temporary differences and carry forwards are expected
to be available to reduce taxable income.  Due to uncertainty  regarding  future
income to offset the loss carry  forward,  Management  has made an allowance for
the entire deferred tax asset.

Advertising Costs

Medical Media  expenses the production  costs of advertising  the first time the
advertising takes place.

Fixed Assets

Medical  Media's fixed assets consist of computer  equipment  being  depreciated
over 3 years and leasehold  improvements  being  depreciated  over the remaining
life of the current lease.

Going Concern

We currently are a development stage company under the provisions of SFAS No. 7,
and have  negative  cash  flows from  operations  and no  established  source of
revenue.  We do not anticipate  significant  revenues from advertising  sales or
subscription  sales until the first quarter of 2007. The foregoing matters raise
substantial  doubt  about the  ability  of our  Company to  continue  as a going
concern.  Management believes the current cash on hand and anticipated  revenues
may not be sufficient to retire the full amount of the obligations  described in
the section entitled  "Liquidity and Capital  Resources," that mature during the
next twelve months.  As such,  the Company may seek external  sources to satisfy
these obligations.  Failure to obtain such funding would have a material adverse
effect on the Company's results of operations and financial condition.



                                       10
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Use of Estimates

Our  financial  statements  have been  prepared in  accordance  with  accounting
principles  generally  accepted in the United States.  The  preparation of these
financial  statements  requires us to make  significant  estimates and judgments
that affect the reported amounts of assets, liabilities,  revenues, expenses and
related  disclosure  of  contingent  assets and  liabilities.  We  evaluate  our
estimates,  including  those related to  contingencies,  on an ongoing basis. We
base our estimates on  historical  experience  and on various other  assumptions
that are believed to be reasonable under the circumstances, the results of which
form the basis for  making  judgments  about the  carrying  values of assets and
liabilities that are not readily apparent from other sources. Actual results may
differ from these estimates under different assumptions or conditions.

NOTE B - COMMON AND PREFERRED STOCK

Start of trading on the OTC Bulletin Board

On  February  2,  2004,  Medical  Media's  Common  Stock  began  trading  on the
OTC-Bulletin  Board under the symbol PTNW. In April 2005,  our symbol changed to
"MMTV".  There is a limited  public  trading  market for our Common  Stock and a
regular, more active trading market may not develop, or if developed, may not be
sustained.

Common Stock

On April 5, 2005,  the Company  combined  its issued and  outstanding  shares of
Common Stock on a 1:30 basis effective as of May 4, 2005.

On January 10, 2006, the Company  issued 10,000 shares of its restricted  Common
Stock to each  member  of the  PetCARE  TV  Veterinary  Advisory  Board in their
advisory capacities, for an aggregate of 130,000 shares.

On January 10, 2006, the Company  issued 10,000 shares of its restricted  Common
Stock to each member of the African  American  Medical Network Medical  Advisory
Board in their advisory capacities, for an aggregate of 60,000 shares.

On January 18, 2006, the Company  issued 56,195 shares of its restricted  Common
Stock to  Jeffery  Werber,  DVM,  a  director  and  Chairman  of the  PetCARE TV
Veterinary Advisory Board, in satisfaction of invoices totaling $22,478.

On March 6, 2006,  the Company  issued  41,670 shares of its  restricted  Common
Stock to Vicis  Capital  Master  Fund upon the  exercise  of its Series C Common
Stock Purchase  Warrants through the payment of $6,917.22 to the Company.  These
shares were  registered  under a  registration  statement  on Form SB-2 that was
declared effective by the Securities & Exchange Commission on March 1, 2006.

On March 6, 2006, the Company  issued  104,167  shares of its restricted  Common
Stock to Vicis  Capital  Master  Fund upon the  exercise  of its Series F Common
Stock Purchase Warrants through the payment of $17,192.71 to the Company.  These
shares were  registered  pursuant to a registration  statement on Form SB-2 that
was declared effective by the Securities & Exchange Commission on March 1, 2006.


                                       11
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE B - COMMON AND PREFERRED STOCK (Continued)

Preferred stock

Series A Zero Coupon Preferred Stock

The Company's Series A Zero Coupon  Preferred Stock is non-voting  capital stock
with a stated  value of $1.00 per share and is  convertible  into the  Company's
Common  Stock at the option of the holder any time after the date of issuance at
the  initial  rate  of  $2.40  per  share.  In the  event  of any  voluntary  or
involuntary liquidation,  dissolution, or winding up of the Company, the holders
of shares of Series A Zero Coupon Preferred Stock are entitled to be paid out of
the assets  available  for  distribution  an amount  equal to One Million  Three
Hundred  Seventy  Five  Thousand  and  No/100  Dollars  ($1,375,000).  There are
currently  1,682,044  shares of Series A Zero Coupon  Preferred Stock issued and
outstanding.  The common shares  underlying  the Series A Zero Coupon  Preferred
Stock were included in a registration  statement on Form SB-2 filed with the SEC
which was declared effective on March 1, 2006.

Series B Zero Coupon Preferred Stock

The Company's Series B Zero Coupon  Preferred Stock is non-voting  capital stock
with a stated  value of $1.00 per share and is  convertible  into the  Company's
Common  Stock at the option of the holder any time after the date of issuance at
the initial rate of $3.00 per share.  Of the  2,612,329  shares of Series B Zero
Coupon  Preferred  Stock issued and  outstanding,  Vicis Capital owns  2,551,918
shares at an adjusted conversion price of $0.166 per share and Mark Maltzer owns
60,411  shares  at a  conversion  rate of $2.40 per  share.  In the event of any
voluntary or involuntary liquidation, dissolution, or winding up of the Company,
the holders of shares of Series B Zero Coupon Preferred Stock are entitled to be
paid out of the assets available for distribution  after taking into account the
Series A Zero Coupon  Preferred  Stock  liquidation  preference,  but before any
payment  shall be made to the  holders  of Common  Stock or any  other  class or
series  of stock  ranking  on  liquidation  junior to the  Series B Zero  Coupon
Preferred  Stock,  an amount  equal to Two Million  Three  Hundred  Thousand and
No/100  Dollars  ($2,300,000).  The common shares  underlying  the Series B Zero
Coupon  Preferred  Stock were included in a registration  statement on Form SB-2
filed with the SEC that was declared effective on March 1, 2006.

Series C Zero Coupon Preferred Stock

The Company's Series C Zero Coupon  Preferred Stock is non-voting  capital stock
and has a stated value of $1.00 per share and is convertible  into the Company's
Common  Stock at the option of the  holder  any time after the date of  issuance
into that number of shares of our Common Stock determined by dividing the number
of shares of Preferred Stock by the conversion  price  (initially equal to a ten
percent  (10%)  discount to the  then-current  market price based on the average
closing price for the twenty (20) days immediately preceding the conversion.  In
the event of any voluntary or involuntary liquidation,  dissolution,  or winding
up of the Company, the holders of shares of Series C Zero Coupon Preferred Stock
are  entitled  to be paid out of the assets  available  for  distribution  after
taking  into  account  the  liquidation  preference  of the Series A Zero Coupon
Preferred Stock and Series B Zero Coupon Preferred Stock, but before any payment
shall be made to the  holders  of Common  Stock or any other  class or series of
stock ranking on liquidation junior to the Series C Zero Coupon Preferred Stock,
an amount equal to Four Hundred  Thousand and No/Dollars  ($400,000).  There are
currently  12,642  shares of Series C Zero  Coupon  Preferred  Stock  issued and
outstanding.  The pool of common  shares  underlying  the  Series C Zero  Coupon
Preferred  Stock were  included in a  registration  statement on Form SB-2 filed
with the SEC that was declared on effective on March 1, 2006.


                                       12
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE B - COMMON AND PREFERRED STOCK (Continued)

Treasury stock

Treasury stock is shown at cost.

Stock Options

We had an equity  incentive plan  available to key employees and  consultants of
the Company.  Under the plan,  we may grant  options for up to 66,667  shares of
Common  Stock.  In October  2003,  the Company  granted 5,300 options under this
equity  incentive  plan.  On March 23, 2006,  the  Company's  Board of Directors
approved  the granting of the  remaining  61,317  options.  With the issuance of
these options in April 2006, the 2002 Equity Incentive Plan was closed.

Effective  July 25,  2006,  by written  action  completed  on August 7, 2006,  a
majority  of  the  Company's   shareholders  approved  the  2006  Medical  Media
Television,  Inc.  Equity  Incentive Plan with an effective date of May 1, 2006.
Under the plan, we may grant options for up to 2,500,000 shares of Common Stock.
The Company has authorized  the issuance of 654,636  shares under  non-qualified
options under this plan.

NOTE C - RELATED PARTY TRANSACTIONS

On May 16,  2002,  we issued a  non-interest  bearing  promissory  note to James
Calaway,  a former director,  in the original  principal amount of $100,000 (the
"Calaway Note"). At September 30, 2006, the principal balance due on the Calaway
Note was $60,999.

In June 2002, we issued the following non-interest bearing promissory notes (the
"Hugo/Turner Notes"), all of which remained outstanding at September 30, 2006:

      Daniel V. Hugo, a former officer and director, in the amount of $25,000;
      Robert and Janna Hugo, in the amount of $6,000; and
      Robert and Jamie Turner, in the amount of $5,000.

At September 30, 2006, the principal  balances due on the Hugo/Turner Notes were
$16,668, $4,000, and $3,332 respectively.

On May 11, 2005, as amended by that certain First Amendment to Merger  Agreement
dated November 16, 2005, the Company  executed that certain Merger Agreement (as
amended, the "Merger Agreement") by and among AFMN, Inc., a Delaware corporation
("AFMN"),  African  American Medical  Network,  Inc., a Florida  corporation and
wholly-owned  subsidiary of AFMN ("African American Medical Network"),  and AAMN
Acquisition Sub, Inc., a Florida corporation and wholly-owned  subsidiary of the
Company.  Pursuant to the Merger  Agreement,  Medical  Media  issued  19,415,626
shares of its restricted common stock (the "Medical Media Common Stock") to AFMN
in  exchange  for 100% of the  outstanding  shares of African  American  Medical
Network. Under the Merger Agreement, AFMN agreed to distribute the Medical Media
Common Stock pro-rata to its  shareholders of record as of November 16, 2005. On
November 16, 2005,  the parties  consummated  the merger in accordance  with the
terms of the Merger  Agreement  and the Company  issued the Medical Media Common
Stock to AFMN in  reliance  upon the  exemption  from  registration  provided by
Section 4(2) of the  Securities  Act of 1933. On February 10, 2006,  the Company
filed a registration statement on Form SB-2 (the "Registration  Statement") with
the Securities and Exchange  Commission (the  "Commission")  registering,  among
other  securities,  the Medical Media Common Stock. The Commission  declared the
Registration Statement effective on March 1, 2006. Shortly thereafter,  pursuant
to the Merger Agreement,  the Medical Media Common Stock was distributed to AFMN
shareholders of record as of November 16, 2005. Certain shareholders of AFMN who
received the Medical Media Common Stock as a result of the merger were directors
and executive  officers of the Company.  The table below  provides the names and
number of shares of the Company each director and officer  received  pursuant to
the Merger Agreement in their capacity as shareholders of AFMN.


                                       13
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

<TABLE>
<CAPTION>
------------------------------------------------------ ------------------------------ ---------------------------------
                                                        No. of shares beneficially     No. of shares of Medical Media
             Name and Relationship with                     held in AFMN, Inc.         Television, Inc. received as a
           Medical Media Television, Inc.                 as of November 16, 2005        result of the Transaction.
------------------------------------------------------ ------------------------------ ---------------------------------
<S>                                                              <C>                             <C>
Philip M. Cohen(1)
President, Chief Executive Officer and
Chairman of the Board of Directors                               1,055,000                       1,055,000
------------------------------------------------------ ------------------------------ ---------------------------------
Donald R. Mastropietro(2)
Vice President of Finance, Chief Financial Officer,
Treasurer, and Asst. Sec.                                         748,667                         748,667
------------------------------------------------------ ------------------------------ ---------------------------------
Teresa Bray(3)
Vice President of Administration and Secretary                    670,000                         670,000
------------------------------------------------------ ------------------------------ ---------------------------------
Jeffrey I. Werber
Director                                                             0                               0
------------------------------------------------------ ------------------------------ ---------------------------------
Bernard J. Kouma
President of PetCARE Television Network, Inc.                        0                               0
------------------------------------------------------ ------------------------------ ---------------------------------
John Sfondrini
Director                                                             0                               0
------------------------------------------------------ ------------------------------ ---------------------------------
J. Holt Smith
Director                                                          200,000                         200,000
------------------------------------------------------ ------------------------------ ---------------------------------
Michael Marcovsky
Director                                                          200,000                         200,000
------------------------------------------------------ ------------------------------ ---------------------------------
Stanley Raphael
Director                                                             0                               0
------------------------------------------------------ ------------------------------ ---------------------------------
Total                                                            2,873,667                       2,873,667
------------------------------------------------------ ------------------------------ ---------------------------------
</TABLE>

1     This includes  130,000 shares  beneficially  held by Mr. Cohen through his
      wife,  Sondra  Topper and  925,000  shares held by Mr.  Cohen's  immediate
      family  members,  which are  required to be  included  in this  disclosure
      pursuant to Item 404 of  Regulation  S-B. Mr. Cohen  disclaims  beneficial
      ownership of the 925,000  shares held by his immediate  family members for
      any other purpose.

2     This includes  733,667 shares  beneficially  held by Mr.  Mastropietro and
      15,000 shares held by Mr. Mastropietro's  immediate family members,  which
      are  required to be included  in this  disclosure  pursuant to Item 404 of
      Regulation S-B. Mr.  Mastropietro  disclaims  beneficial  ownership of the
      15,000 shares held by his immediate family members for any other purpose.

3     This includes  435,000  shares  beneficially  held by Ms. Bray and 215,000
      shares held by Ms. Bray's immediate family members,  which are required to
      be included in this disclosure pursuant to Item 404 of Regulation S-B. Ms.
      Bray  disclaims  beneficial  ownership  of the 215,000  shares held by her
      immediate family members for any other purpose.

NOTE D - CONVERTIBLE PROMISSORY NOTES

On May 6, 2005,  the Company  issued to Vicis  Capital  Master Fund  ("Vicis") a
Series B Convertible  Debenture  (the  "Debenture")  in the principal  amount of
$250,000,  and  related  Series D, Series E and Series F Common  Stock  Purchase
Warrants.  The Debenture has a term of 24 months and accrues  interest an annual
rate of fifteen  percent  (15%).  The Company has the option to pay  interest in
cash or in shares of its registered common stock at a ten percent (10%) discount
to the  market  price,  as  calculated  pursuant  to the  express  terms  of the


                                       14
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE D - CONVERTIBLE PROMISSORY NOTES (Continued)

Debenture.  At  maturity,  Vicis may  convert the  Debenture  into shares of the
Company's  Common Stock at a price of $2.40 per share.  On October 19, 2005, the
conversion  price was reduced to $0.166  pursuant to the extension  terms of the
Series AA Convertible Debenture described in further detail below.

On November 16, 2005, the Company issued Series AA Convertible Debenture, Series
AA Common Stock Purchase Warrants,  and Series BB Common Stock Purchase Warrants
to Vicis.  Pursuant to the terms of the Series AA Convertible  Debenture,  Vicis
loaned the  Company an  aggregate  of  $412,000 at an annual rate of interest of
sixteen  percent  (16%).  The Series AA  Convertible  Debenture was cancelled on
August 11, 2006 and became part of a Secured  Convertible  Promissory Note dated
August 11, 2006 in the amount of $1,302,000.

On November  16,  2005,  the Company  issued a  Promissory  Note for $100,000 to
Laurence Wallace (the "Wallace  Promissory  Note") at an annual interest rate of
eight percent (8%). On the maturity date of the Wallace  Promissory  Note (April
17, 2006),  Wallace had the option to execute a debt conversion  agreement under
which the  principal  amount of the Wallace  Promissory  Note would convert into
100,000  units of the  Company's  securities,  each unit  consisting  of (i) two
shares of Medical Media's Common Stock (for an aggregate of 200,000 shares), and
(ii) one Common Stock  Purchase  Warrant to purchase an additional  share of the
Company's  Common Stock (for an aggregate of 100,000  warrants) with an exercise
price of $1.00 per share.  On October 12,  2006,  the  Company  and Mr.  Wallace
entered  into a letter of  extension  whereby the  maturity  date on the Wallace
Promissory Note was extended to April 15, 2007 (the  "Extension").  Terms of the
Extension include a payment of $5,000 on each of October 1, October 15, November
15, and December 15, 2006, and January 15,  February 15, and March 15, 2007, and
a final  payment  on April 15,  2007 of  $65,000  plus any  accrued  and  unpaid
interest.  Terms of the  Extension  canceled all  conversion  rights  previously
granted under the Wallace  Promissory Note and issued Wallace  three-year Common
Stock Purchase Warrants to purchase 100,000 shares of the Company's Common Stock
with a fixed  exercise  price of $0.17 per share.  As of November 17, 2006,  the
balance due is $100,000.

On November  16,  2005,  the Company  issued a  Promissory  Note for $200,000 to
Carmen Bernstein (the "Bernstein Promissory Note") at an annual interest rate of
ten  percent  (10%).  On the  maturity  date of the  Bernstein  Promissory  Note
(December  14,  2005),  Bernstein  had the option to  execute a debt  conversion
agreement  under which the  principal  amount of the Bernstein  Promissory  Note
would  convert  into  200,000  units  of the  Company's  securities,  each  unit
consisting of (i) one share of the  Company's  Common Stock (for an aggregate of
200,000  shares),  and (ii) one Common Stock  Purchase  w\Warrant to purchase an
additional  share of the Company's  Common  s\Stock (for an aggregate of 200,000
warrants)  with an exercise price of $2.00 per share.  The Bernstein  Promissory
Note was extended  indefinitely by mutual verbal  agreement.  As of November 17,
2006, the balance due is $145,000.

On  November  30,  2005,  the  Company  issued to William  H.  Quiros a 12-month
Convertible  Promissory  Note  ("November  Quiros  Note")  for  $1,000,000  with
interest  accruing  at the rate of twenty  percent  (20%) per annum,  compounded
semi-annually.  Interest was to be paid at the end of each  calendar  quarter in
either shares of Series C Zero Coupon  Preferred  Stock of the Company valued at
$1.00 per share,  or cash,  at the option of  Quiros.  The Series C Zero  Coupon
Preferred  Stock would convert into shares of the Company's  Common Stock on the
maturity date of the November Quiros Note at a ten percent (10%) discount to the
then-current market price based on the average closing price for the twenty (20)
days  immediately  preceding the  conversion.  On December 31, 2005, the Company


                                       15
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE D - CONVERTIBLE PROMISSORY NOTES (Continued)

issued 8,627 shares of its Series C Zero Coupon  Preferred  Stock as payment for
$8,627  interest  accrued  through  December  31,  2005.  The 8,627  shares  are
convertible into 9,586 shares of the Company's Common Stock. At maturity, Quiros
had the option to convert the  November  Quiros  Note into  Common  Stock of the
Company at a fixed  conversion  price of $.40 per share. The Company also issued
Quiros five-year Common Stock Purchase Warrants ("Quiros  Warrants") to purchase
an aggregate of 2,500,000  shares of common stock at a Fixed  Exercise  price of
$0.75 per share.  On July 28, 2006,  the Company and Quiros  agreed to amend the
terms of the November Quiros Note as follows: (i) the Maturity Date was extended
to November 30, 2008; (ii) the note would not be convertible  until the Maturity
Date;  (iii) the  Company  would  have the  option to repay the note at any time
prior to the Maturity Date; (iv) the conversion price on the note was changed to
an amount equal to a twenty  percent (20%) discount to the  then-current  market
price based on the average  closing  price for the twenty (20) days  immediately
preceding  the  conversion,  but in no event less than  $0.166  per  share;  (v)
quarterly  interest  payments  on the note would be applied  toward the  balance
remaining  unpaid  under the March Quiros Note (as  described  below) until such
time as the entire $450,000 under the March Quiros Note has been received by the
Company,  at which time all future interest will accrue, but will not become due
and payable  until the maturity  date;  and (vi)  certain  price  ratchets  were
deleted.  The November Quiros Warrants were also amended to delete certain price
ratchets.  The November Quiros Note and the  accompanying  Common Stock Purchase
Warrants are not  convertible  or exercisable  such that Quiros'  overall Common
Stock ownership position in the Company exceeds 4.99%;  provided,  however, that
upon Quiros  providing the Company with  sixty-one (61) days notice (the "Waiver
Notice") that he would like to waive this  restriction with regard to any or all
shares of Common Stock issuable upon exercise of the  conversion  feature of the
November Quiros Note, this restriction will be of no force or effect with regard
to all or a portion of the November Quiros Note referenced in the Waiver Notice,
and provided  further that this provision shall be of no further force or effect
during the sixty-one (61) days immediately  preceding the expiration of the term
of the November Quiros Note.

On January 27, 2006,  the Company and  CapitalSmart,  LLC, a California  limited
liability company, ("CSmart") entered into a Note Purchase Agreement pursuant to
which  CSmart  agreed to loan the Company an  aggregate  of  $1,000,000  through
installments  of $250,000 on February  15, 2006 and  $750,000 on March 31, 2006.
The Note Purchase Agreement provided that the Company issue Csmart a convertible
promissory  note in the  original  aggregate  face  amount  of  $1,000,000  (the
"CapitalSmart  Note") and five-year  Common Stock Purchase  Warrants to purchase
2,500,000  shares of the  Company's  Common Stock (the "CSmart  Warrants")  at a
Fixed Exercise  Price of $0.75 per share.  The Company issued the CSmart Note on
February 15, 2006 and issued  CSmart  625,000  Warrants.  The CSmart Note was to
mature twelve months from the date of issuance (the "Maturity Date") and accrued
interest at a rate of 20%  (compounded  semi-annually).  Interest was payable at
the end of each  quarter  in either (i)  shares of the  Company's  Series C Zero
Coupon  Preferred Stock valued a $1.00 per share, or (ii) cash, at the option of
CSmart.  The first interest  payment due on March 31, 2006 of $6,438 was paid on
April 1, 2006 in cash.  On the Maturity  Date,  CSmart had the option to convert
the CSmart Note into shares of the Company's  Common Stock at a fixed conversion
price of $0.40 per share.  As of July 28,  2006,  CSmart had loaned the  Company
$624,580.50  and CSmart and the Company agreed to cancel the Csmart Note and the
outstanding  625,000  CSmart  Warrants,  and to issue in lieu thereof,  separate
replacement  convertible  promissory  notes and  warrants to the  principals  of
CSmart or to entities  controlled  by the  principals  of CSmart.  In accordance
therewith,  four convertible promissory notes in an aggregate amount equal to $1
million were issued to: Softrev Partners, Inc. for $250,000, Gilbert B. Ross for
$200,000,  William H. Quiros for  $450,000,  and Steven Port for  $100,000.  The
notes,  described  in  detail  herein,  were  issued  on July 28,  2006  with an
effective date as to when each principal  contributed funds to the Company to be
applied toward the CSmart Note balance.


                                       16
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE D - CONVERTIBLE PROMISSORY NOTES (Continued)

On February 15, 2006, the Company issued a Convertible Promissory Note to Steven
J. Port for  $100,000  (the  "February  Port Note") and  five-year  Common Stock
Purchase  Warrants to purchase 250,000 shares of the Company's Common Stock at a
Fixed  Exercise Price of $0.75 per share (the  "February  Port  Warrants").  The
February Port Note was issued as a partial  replacement  for the CSmart Note for
$1,000,000  described  above.  The February  Port Note will mature twelve months
from the date of issuance (the "Maturity Date") and accrues interest at the rate
of 20% compounded semi-annually. At the option of Port, interest will be paid at
the end of each  quarter  in either (i)  shares of the  Company's  Series C Zero
Coupon  Preferred Stock valued a $1.00 per share, or (ii) cash. With the consent
of both the  Company and Port,  the  February  Port Note may be extended  for an
additional 12 months with the terms of the interest payments remaining the same.
The Port Note is not convertible  until the Maturity Date. On the Maturity Date,
Port has the  option to  convert  the  February  Port  Note  into  shares of the
Company's  Common  Stock at a price equal to forty cents  ($0.40),  or an amount
equal to a twenty percent (20%) discount to the then-current  market price based
on the average closing price for the twenty (20) days immediately  preceding the
conversion, with the exception that the Conversion Price shall not be lower than
$0.166.

On February  16,  2006,  the Company  issued a  Convertible  Promissory  Note to
Gilbert B. Ross for  $200,000  (the  "Ross  Note") and  five-year  Common  Stock
Purchase  Warrants to purchase 500,000 shares of the Company's Common Stock at a
Fixed Exercise Price of $0.75 per share (the "Ross Warrants"). The Ross Note was
issued as a partial  replacement  for the CSmart Note for  $1,000,000  described
above.  The Ross Note will mature  three  years from the date of  issuance  (the
"Maturity  Date") and accrues  interest at the rate of twenty  percent (20%) per
annum. Interest accrues but is not due and payable until the Maturity Date. With
the consent of both the Company and Ross,  the Ross Note may be extended  for an
additional  12-month term, with the terms of the interest payments remaining the
same. The Ross Note is not convertible  until the Maturity Date. On the Maturity
Date,  Ross has the option to convert the Ross Note into shares of the Company's
Common  Stock  at a price  equal  to a  twenty  percent  (20%)  discount  to the
then-current market price based on the average closing price for the twenty (20)
days immediately preceding the conversion,  but in no event shall the Conversion
Price be less than $0.166 per share.

On March 31, 2006, the Company issued a Convertible  Promissory  Note to William
H. Quiros for $450,000 (the "March  Quiros Note") and agreed to issue  five-year
Common Stock  Purchase  Warrants to purchase  1,125,000  shares of the Company's
Common  Stock at a Fixed  Exercise  Price of $0.75 per share (the "March  Quiros
Warrants").  The March Quiros Note was issued as a partial  replacement  for the
CSmart Note for $1,000,000 described above. Per the terms of the November Quiros
Note, as amended,  quarterly interest payments on the November Quiros Note would
be applied toward the balance remaining unpaid under the March Quiros Note until
the  Company has  received  the entire  $450,000  under the March  Quiros  Note.
Additionally,  quarterly  interest  payments  on the March  Quiros Note would be
applied  toward the balance  remaining  unpaid under the March Quiros Note until
the  entire  $450,000  under  the March  Quiros  Note has been  received  by the
Company,  at which time all future interest will accrue, but will not become due
and payable  until the  maturity  date.  The March Quiros Note will mature three
years from the date of issuance (the "Maturity  Date") and accrues interest at a
rate of twenty  percent  (20%) per annum.  Interest  accrues  but is not due and
payable  until the  Maturity  Date.  With the  consent of both the  Company  and
Quiros,  the March Quiros Note may be extended for an additional  12-month term,
with the terms of the interest  payments  remaining  the same.  The March Quiros
Note is not  convertible  until the Maturity Date. On the Maturity Date,  Quiros
has the option to convert the March  Quiros  Note into  shares of the  Company's
Common  Stock  at a price  equal  to a  twenty  percent  (20%)  discount  to the


                                       17
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE D - CONVERTIBLE PROMISSORY NOTES (Continued)

then-current market price based on the average closing price for the twenty (20)
days immediately preceding the conversion,  but in no event shall the Conversion
Price be less than $0.166 per share.  As of September  30, 2006,  Mr. Quiros had
loaned the Company $128,751 under the March Quiros Note.

On March 31, 2006, the Company issued a Convertible Promissory Note to Elaine G.
Edinburg for $10,000 (the "Edinburg  Note") and five-year  Common Stock Purchase
Warrants to purchase  25,000  shares of the  Company's  Common  Stock at a Fixed
Exercise Price of $0.75 per share (the "Edinburg  Warrants").  The Edinburg Note
matures  twelve  months  from the date of  issuance  (the  "Maturity  Date") and
accrues interest at a rate of twenty percent (20%) compounded semi-annually.  At
the  option of  Edinburg,  interest  will be paid at the end of each  quarter in
either (i) shares of the Company's Series C Zero Coupon Preferred Stock valued a
$1.00 per share, or (ii) cash. On the Maturity Date,  Edinburg had the option to
convert the Edinburg Note into shares of the  Company's  Common Stock at a Fixed
Conversion  Price of $0.40 per share.  With the  consent of both the Company and
Edinburg, the Edinburg Note may be extended for an additional twelve (12) months
with the terms of the interest  payments  remaining  the same. On June 20, 2006,
Edinburg and the Company agreed to amend the Edinburg Note and Edinburg Warrants
as follows:  (i) the conversion price was changed to the Investor's option of an
amount equal to forty cents ($0.40) or an amount equal to a twenty percent (20%)
discount to the then-current market price based on the average closing price for
the twenty (20) days  immediately  preceding the conversion,  with the exception
that the  Conversion  Price  shall  not be lower  than  $0.166;  and (ii)  price
ratchets were deleted.  On September 30, 2006,  the Company issued 998 shares of
its Series C Zero Coupon  Preferred  Stock as payment for $998 interest  accrued
through September 30, 2006.

On April 1, 2006, the Company issued a Convertible  Promissory Note to Steven J.
Port for $125,000  made in  installments  (the "April Port Note") and  five-year
Common  Stock  Purchase  Warrants to purchase  312,500  shares of the  Company's
Common  Stock at a Fixed  Exercise  Price of $0.75 per share  (the  "April  Port
Warrants"). The original maturity date of the April Port Note was April 30, 2006
and interest  accrues at the rate of twenty  percent  (20%) per annum.  Interest
accrues, but is not due and payable until the Maturity Date. The April Port Note
automatically  extends to the end of each  succeeding  month  until such time as
Port  provides a 15-day  written  notice to the Company that the April Port Note
may no longer be automatically  extended.  The terms of interest will remain the
same throughout the automatic  extension periods. On the Maturity Date, Port has
the option to convert  the April Port Note into shares of the  Company's  Common
Stock at a price equal to an amount equal to forty cents  ($0.40),  or an amount
equal to a twenty percent (20%) discount to the then-current  market price based
on the average closing price for the twenty (20) days immediately  preceding the
conversion, with the exception that the Conversion Price shall not be lower than
$0.166.  On September 30, 2006, the Company issued 11,644 shares of its Series C
Zero Coupon  Preferred  Stock as payment for $11,644  interest  accrued  through
September 30, 2006.

On April 16, 2006, the Company issued a Convertible  Promissory  Note to Softrev
Partners,  Inc. for $250,000  (the "Softrev  Note") and  five-year  Common Stock
Purchase  Warrants to purchase 625,000 shares of the Company's Common Stock at a
Fixed  Exercise Price of $0.75 per share (the "Softrev  Warrants").  The Softrev
Note was  issued as a partial  replacement  for the CSmart  Note for  $1,000,000
described  above. The Softrev Note matures three years from the date of issuance
(the "Maturity Date") and accrues interest at a rate of twenty percent (20%) per
annum. Interest accrues but is not due and payable until the Maturity Date. With
the consent of both the Company and  Softrev,  the Softrev  Note may be extended
for an  additional  12-month  term,  with  the  terms of the  interest  payments
remaining the same.


                                       18
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE D - CONVERTIBLE PROMISSORY NOTES (Continued)

The  Softrev  Note shall not be  convertible  until the  Maturity  Date.  On the
Maturity Date, Softrev has the option to convert the Softrev Note into shares of
the Company's  Common Stock at a price equal to a twenty  percent (20%) discount
to the  then-current  market  price based on the average  closing  price for the
twenty (20) days immediately preceding the conversion, but in no event shall the
Conversion Price be less than $0.166 per share.

On June 1,  2006,  the  Company  issued a Secured  Promissory  Note to Vicis for
$50,000  ("Vicis  June 1 Secured  Note").  The Vicis June 1 Secured  Note was to
mature on December 31, 2006 and accrued  interest at a rate of eighteen  percent
(18%) per annum.  The Vicis  June 1 Secured  Note was  secured  by all  accounts
receivable due from Butler Animal Health Supply after June 1, 2006, or any other
money due the Company from any and all other  sources.  The Vicis June 1 Secured
Note could be prepaid in whole or in part at any time, with a prepayment penalty
of $5,492.25.  On August 11, 2006,  Vicis  surrendered  the Vicis June 1 Secured
Note  as  partial   consideration  for  the  Company's  issuance  of  a  Secured
Convertible Promissory Note in the principal amount of $1,302,000.

On June 30,  2006,  the Company  issued a Secured  Promissory  Note to Vicis for
$50,000  ("Vicis June 30 Secured  Note").  The Vicis June 30 Secured Note was to
mature on January 31, 2007 and  accrued  interest at a rate of eighteen  percent
(18%) per  annum.  The Vicis June 30 Secured  Note was  secured by all  accounts
receivable  due from Butler  Animal  Health  Supply after June 30, 2006,  or any
other money due the Company  from any and all other  sources.  The Vicis June 30
Secured Note could be prepaid in whole or in part at any time, with a prepayment
penalty of $5,492.25.  On August 11, 2006,  Vicis  surrendered the Vicis June 30
Secured Note as partial  consideration  for the Company's  issuance of a Secured
Convertible Promissory Note in the principal amount of $1,302,000.

On August 11, 2006, the Company issued a 10% Secured Convertible Promissory Note
in the  principal  amount of  $1,302,000  (the "Note") to Vicis  pursuant to the
terms of a Note Purchase  Agreement.  As  consideration  for the Note, Vicis (a)
delivered  $790,000 in cash (the "Cash  Payment");  (b)  surrendered two secured
promissory  notes  issued by the Company to Vicis on June 1, 2006,  and June 30,
2006, respectively,  each in the principal amount of $50,000 (collectively,  the
"June Notes"); and (c) surrendered a Series AA Convertible Debenture No. 05-0719
issued by the  Company to Vicis on July 19,  2005,  in the  principal  amount of
$412,000  (the  "Debenture").  At any time while the Note  remains  outstanding,
Vicis may convert the outstanding  principal  balance and any accrued but unpaid
interest on the Note into shares of the Company's Common Stock, par value $.0005
per share, at a conversion price of $.166 per share (the  "Conversion  Shares").
The  principal  balance of the Note is due in one lump sum payment on August 10,
2007 (the "Maturity Date"), unless earlier converted. Interest on such principal
(or any balance thereof outstanding from time to time) accrued at an annual rate
of interest  of ten  percent  (10%) and was  payable on the  Maturity  Date.  As
security for the  Company's  obligations  under the Purchase  Agreement  and the
Note,   the  Company   pledged  all  of  the  capital  stock  of  the  Company's
subsidiaries,  PetCARE TV,  African  American  Medical  Network,  and KidCARE TV
(collectively the  "Subsidiaries"),  pursuant to the terms of a Stock Pledge and
Escrow Agreement,  dated August 11, 2006. Repayment of the Note is guaranteed by
the Subsidiaries and is also secured by a blanket lien encumbering the assets of
the Company and the  Subsidiaries.  As an  inducement  for Vicis to purchase the
Note,  Philip M. Cohen,  President and Chief  Executive  Officer of the Company,
agreed to amend his employment agreement to include a three (3) year non-compete
clause.


                                       19
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE E - COMMITMENTS AND CONTINGENCIES

On June 5, 2002,  the Company  entered into an Employment  Agreement  ("Original
Agreement")  with Philip Cohen.  On March 23, 2006,  the Original  Agreement was
replaced it its entirety with an Amended Employment Agreement ("Agreement") with
respect  to the  provision  of  services  as our  Chief  Executive  Officer  and
President. On August 11, 2006, as an inducement for Vicis Capital Master Fund to
loan the  Company  $1,302,000,  Mr.  Cohen  agreed to  execute a Second  Amended
Employment Agreement that added certain non-compete  provisions for a three-year
period following termination of the agreement.

In August 2003, the Company  entered into a sixty-two (62) month lease agreement
commencing  on October 1, 2003 with Liberty  Property  Limited  Partnership  for
approximately  3,800  square  feet of  office/warehouse  space  located  at 8406
Benjamin Road,  Suite C, Tampa,  Florida 33634.  Under this  agreement,  minimum
lease expense for the 12 months ended  December 31, 2006 and 2007 and the eleven
months  ended  November  30, 2008 will be  approximately,  $40,300,  $41,100 and
$38,500 respectively.

At December 31, 2005,  the Company had a consulting  agreement in place with Mr.
James Calaway, a member of its Board of Directors. The agreement states that Mr.
Calaway provide financial consulting services,  at the direction of the Board of
Directors, for the amount of $667 per month.

On June 1, 2005, PetCARE TV entered into an employment agreement with Bernard J.
Kouma  with  respect  to the  provision  of  services  as its  President,  which
agreement  terminates  on May 31, 2010,  with a base salary of $72,000 per year.
The agreement also contains a two-year non-compete clause.

On  November  16,  2005,  African  American  Medical  Network  entered  into  an
employment  agreement  with Robert  Cambridge  with respect to the  provision of
services as its President, which agreement terminates on November 15, 2010, with
a base  salary of  $72,000  per year.  The  agreement  also  contains a two-year
non-compete  clause. On September 1, 2006, the Company and Mr. Cambridge entered
into a Settlement and Termination  Agreement in which Mr.  Cambridge  agreed to:
(i) terminate his employment agreement, (ii) submit his resignation as President
of African  American Medical  Network,  and (iii) release and forever  discharge
African  American Medical from and against any and all future claims arising out
of, in connection  with, or relating to Mr. Cambridge having acted as an officer
of African American Medical.  African American Medical agreed to: (i) accept the
resignation  of Mr.  Cambridge,  and (ii)  release  and  forever  discharge  Mr.
Cambridge  from  any  against  any and all  future  claims  arising  out of,  in
connection  with,  or relating to the duties of Mr.  Cambridge  as  President of
African  American  Medical.  Mr.  Cambridge and African American Medical Network
gave mutual releases and waivers.

On November 16, 2005,  the Company  entered into an  employment  agreement  with
Donald R. Mastropietro with respect to the provision of services as our Sr. Vice
President Finance, Chief Financial Officer,  Treasurer, and Assistant Secretary,
which agreement  terminates on November 15, 2010, with a base salary of $128,400
per year. The agreement also contains a two-year non-compete clause.

On November 16, 2005,  the Company  entered into an  employment  agreement  with
Charles V.  Richardson with respect to the provision of services as our Sr. Vice
President Marketing and Chief Marketing Officer,  which agreement  terminates on
March 31, 2009,  with a base salary of $150,000  per year.  The  agreement  also
contains a two-year non-compete clause.

On November 16, 2005,  the Company  entered into an  employment  agreement  with
Teresa J. Bray with respect to the  provision of services as our Vice  President


                                       20
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2006

NOTE E - COMMITMENTS AND CONTINGENCIES (Continued)

Administration/Compliance  and Secretary, which agreement terminates on November
15, 2010, with a base salary of $118,400 per year. The agreement also contains a
two-year non-compete clause.

On March 1, 2006, KidCARE TV entered into an employment agreement with Elaine K.
Mann with respect to the provision of services as its President, which agreement
terminates  on February  28, 2009,  with a base salary of $72,000 per year.  The
agreement also contains a two-year non-compete clause.

NOTE F - CONTRACTS

On January 1, 2006,  the Company  entered into a one-year  Consulting  Agreement
with Saddle Ranch  Productions,  Inc. ("Saddle Ranch"),  a Florida  corporation,
wherein Saddle Ranch will provide consulting services; specifically relating to:
(i) all areas of video  production,  editing,  and mastering;  (ii) all areas of
marketing,  specifically  related to  geographic  expansion  of the networks and
subscriber  base;  and (iii) all areas of advertising  sales,  including but not
limited to the employment of regional sales directors for the express purpose of
soliciting and obtaining  advertising  contracts  and/or insertion order for the
Company's  networks with  concentration on providing product  adjacencies and/or
exclusivity for  multi-network  purchases.  The Company will pay Saddle Ranch an
aggregate of $19,000 per month for the  consulting  services.  On July 25, 2006,
the Consulting Agreement between the Company and Saddle Ranch Productions,  Inc.
was amended to set out the monthly  amount due of $17,700 for services  rendered
under the contract as well as the addition of a commission for advertising to be
sold.

On January 3, 2006, PetCARE TV entered into a three-year  Distribution Agreement
with  Butler  Animal  Health  Supply  ("Butler  AHS")  granting  Butler  AHS the
exclusive  distribution  rights to sell PetCARE TV's veterinary client education
products (including annual subscriptions to the monthly DVD magazine and Welcome
Home Your New Friend DVDs) to veterinarian  hospitals  within the U.S. Butler is
the  nation's  largest  distributor  of  companion  animal  health  supplies  to
veterinarians.  Headquartered in Dublin,  Ohio,  Butler operates across the U.S.
with 15  distribution  centers  and 8  tele-centers.  Butler  serves over 29,000
veterinary  clinics in all 50 states and  distributes  over 15,000  products for
more than 300 vendors.

On March 13, 2006, PetCARE TV entered into a two-year Affinity Program Agreement
with American Animal Hospital  Association  ("AAHA") granting AAHA the exclusive
distribution  rights to sell PetCARE TV's veterinary  client education  products
(including  annual  subscriptions  to the monthly DVD  magazine and Welcome Home
Your New Friend  DVDs) to all AAHA member  hospitals  within the U.S.  There are
approximately 3,000 AAHA-accredited hospitals and AAHA will be promoting PetCARE
TV's client education programming as a value-added benefit to its membership.


                                       21
<PAGE>

Item 2.     Management's Discussion and Analysis or Plan of Operation.

The following  discussion and analysis provides  information which management of
Medical Media Television, Inc. ("Medical Media" or the "Company") believes to be
relevant  to an  assessment  and  understanding  of  the  Company's  results  of
operations and financial condition. This discussion should be read together with
the Company's  financial  statements and the notes to the financial  statements,
which are  included  in this  report.  This  information  should also be read in
conjunction  with the information  contained in our Annual Report on Form 10-KSB
for the fiscal year ended  December 31, 2005,  including  the audited  financial
statements and notes included therein. Because of the nature of the Company as a
development  stage company,  the reported  results will not necessarily  reflect
future results of operations or financial condition.

Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-QSB contains "forward-looking  statements",  as
that term is defined in the Private  Securities  Litigation  Reform Act of 1995.
These statements  relate to future events or our future  financial  performance.
Some  discussions  in this report may contain  forward-looking  statements  that
involve  risk and  uncertainty.  A number of important  factors  could cause our
actual results to differ materially from those expressed in any  forward-looking
statements  made by us in this  report.  Forward-looking  statements  are  often
identified  by  words  like  "believe,"  "expect,"   "estimate,"   "anticipate,"
"intend,"  "project" and similar words or  expressions  which,  by their nature,
refer to future events.

In some cases, you can also identify  forward-looking  statements by terminology
such  as  "may,"  "will,"  "should,"   "plans,"   "predicts,"   "potential,"  or
"continue,"  or the  negative  of these terms or other  comparable  terminology.
These  statements  are only  predictions  and involve  known and unknown  risks,
uncertainties,  and other factors that may cause our actual  results,  levels of
activity, performance or achievements to be materially different from any future
results, levels of activity, performance or achievements expressed or implied by
these forward-looking statements.

Although  we believe  that the  expectations  reflected  in the  forward-looking
statements  are  reasonable,  we  cannot  guarantee  future  results,  levels of
activity,  or  achievements.  You  should  not place  undue  certainty  on these
forward-looking  statements,  which  apply  only as of the date of this  report.
These forward-looking  statements are subject to certain risks and uncertainties
that could cause actual results to differ materially from historical  results or
our predictions.  Except as required by applicable law, including the securities
laws of the United States, we do not intend to update any of the forward-looking
statements to conform these statements to actual results.

Overview

Medical  Media is a Florida  corporation  organized on October 2, 1989. We are a
development  stage company  focused on  developing,  establishing  and marketing
educational  programming for  distribution  on a monthly basis to  participating
subscribers  to our  veterinary  network,  our medical  network  directed to the
African  American  population,   and  our  pediatric  network.  Our  educational
programming is obtained through an annual  subscription and is funded,  in part,
by  commercial   advertisers  who  benefit  from  an  effective  and  convenient
advertising medium to target their goods and services to consumer patients.  Our
goal is to be recognized as a leading provider of  advertiser-supported  medical
education  programming  for patients and clients  within the  place-based  media
environment of medical specialty offices nationwide.


                                       22
<PAGE>

We  provide   advertiser-supported   patient/parent/client   medical   education
programming  within the  place-based  media  environment  of  medical  specialty
offices  nationwide.  We  have  three  wholly-owned  subsidiaries:  (1)  PetCARE
Television  Network,  Inc. ("PetCARE TV"), (2) African American Medical Network,
Inc. ("African  American Medical  Network");  and (3) KidCARE Medical Television
Network,  Inc.  ("KidCARE  TV"). As discussed in more detail below,  each of our
subsidiaries targets a different consumer base.

Medical  Media  produces  monthly  DVD  magazines  that are  distributed  to the
participating subscribers of PetCARE TV and African American Medical Network. We
plan to provide  monthly  updated  programming  for  KidCARE  TV through  either
monthly DVD  magazines  or through  direct video  streaming at each  subscribing
location. The programming is funded, in part, by commercial advertisers that are
reviewed and  approved by the  advisory  boards  serving  each  subsidiary.  Our
programming is obtained through an annual  subscription with updated programming
provided directly to the subscribers.

PetCARE TV

PetCARE TV's goal is to provide  animal health and welfare  education to a large
number of  consumers of pet  products  and  services  while  serving as a unique
advertising  medium for  companies  that market  those goods and  services.  Our
educational  programming is currently aired in veterinary  practices  across the
U.S.,  Canada,  Puerto Rico, and Australia  where it is viewed by an estimated 6
million  pet owners each  month.  Each month  PetCARE TV provides an updated DVD
magazine focused on optimal  healthcare for animal  companions.  PetCARE TV also
sells an instructional  DVD to veterinarians  for them to give to their clients,
entitled "Welcome Home Your New Friend".

African American Medical Network

African American Medical Network's goal is to provide educational programming to
doctor's offices nationwide serving African American patients, and to provide an
advertising medium for commercial advertisers to target their goods and services
to these consumer  patients.  Our educational  programming is currently aired in
hundreds of physician offices across the U.S. and is targeted to the patients of
the more than  15,000  doctors  who serve the  majority  of the 35 million  U.S.
African Americans.

KidCARE TV

KidCARE TV will target parent consumers in pediatric  waiting rooms  nationwide.
KidCARE  TV is not yet  operational,  but  plans to  establish  a  collaborative
interaction with the viewing audience through its short  informational  segments
developed to create  awareness about  preventative  health  measurers along with
specific  childhood  illnesses  and  issues.  These  segments  are  designed  to
stimulate  the  viewer  to  seek  further  guidance  from  their   pediatrician.
Interspersed   throughout   the   segments,   promotional   pieces  will  appear
demonstrating  related  health  care  items.  KidCARE  TV's  primary  target for
subscribership will be members of the American Academy of Pediatrics. KidCARE TV
also  sells an  instructional  DVD to  physicians  for them to give to their new
parents entitled "Welcome Home Your New Baby."

More  information  about our  Company and our  subsidiaries  can be found on the
following    websites:    www.medicalmediatelevision.com,     www.petcaretv.com,
www.africanamericanmedicalnetwork.com,  and  www.kidcaretv.com.  These  websites
serve  primarily  as an  informational  tool  for  prospective  subscribers  and
advertisers,  who can log on to find out more about our  business  and the goods
and  services  that we  provide.  Prospective  subscribers  are  allowed to view
samples of our current  programming,  review frequently asked questions,  review
our subscription process, and print out a subscription agreement.


                                       23
<PAGE>

We  have  expended  approximately  $7,081,000  through  September  30,  2006  in
developing  our business  plan.  For the period from the  implementation  of our
current business plan (June 2002) through  September 30, 2006, we have generated
revenue of $366,529 from  advertising  and $66,247 from sales of our educational
DVD,  "Welcome Home Your New Friend,"  distributed by our PetCARE TV subsidiary.
During the same period,  we also generated  revenue from  subscription  sales to
veterinarian  offices of  $90,873  of which  $33,270  is  recorded  as  deferred
revenue.

Development Stage Company; Going Concern Issue

We currently are a development stage company under the provisions of SFAS No. 7,
and have  negative  cash  flows from  operations  and no  established  source of
revenue.  We do not anticipate  significant  revenues from advertising  sales or
subscription  sales until the first quarter of 2007. The foregoing matters raise
substantial  doubt  about the  ability  of our  Company to  continue  as a going
concern. Management does not believe the current cash on hand or its anticipated
revenues  will be  sufficient  to  retire  the full  amount  of the  obligations
described in the section entitled "Liquidity and Capital Resources," that mature
during the next twelve months. As such, the Company is actively seeking external
sources to satisfy these obligations.  Failure to obtain such funding would have
a material  adverse effect on the Company's  results of operations and financial
condition.

Our plan of operation  for the  twelve-month  period  following the date of this
Quarterly  Report on Form  10-QSB is to  continue  to  develop  and  market  our
educational programming.  We currently do not have any plans to purchase or sell
any  significant  equipment,  nor do we  currently  anticipate  any  significant
changes in the number of employees. We do not own any real property.

Recent Events

On August 11, 2006, the Company issued a 10% Secured Convertible Promissory Note
in the principal  amount of $1,302,000  (the "Note")  pursuant to the terms of a
Note Purchase Agreement by and between the Company and Vicis Capital Master Fund
("Vicis").  The purchase  price paid for the Note was (a) $790,000 cash; (b) the
surrender  of two  secured  promissory  notes  each in the  principal  amount of
$50,000; and (c) the surrender of Series AA Convertible Debenture No. 05-0719 in
the  principal  amount of $412,000.  Repayment of the Note is  guaranteed by the
Company's  subsidiaries,  PetCARE TV,  African  American  Medical  Network,  and
KidCARE TV, and is also secured by a blanket lien  encumbering the assets of the
Company and its subsidiaries. In addition, as security for the Note, the Company
pledged all of the capital stock of its subsidiaries  pursuant to a Stock Pledge
and Escrow  Agreement  dated  August  11,  2006.  The Note  contains a number of
negative covenants  restricting the Company,  as discussed in more detail in the
Current  Report on Form 8-K filed with the  Securities  and Exchange  Commission
("SEC") on August 17, 2006.

On August 11, 2006, as an  inducement  to Vicis to loan the Company  $1,302,000,
Philip M. Cohen, the Company's  President,  executed a Second Amended Employment
Agreement in which  non-compete  provisions  were added for a three-year  period
following the termination of the employment agreement.

Effective  August 11, 2006,  Randall Maxey resigned as a member of the Company's
Board of Directors.  The resignation  was not the result of a disagreement  with
the Company on any matter  relating to the Company's  operations,  policies,  or
practices.  The Board of Directors  has not yet appointed a new director to fill
the vacancy created by his resignation.

On July 25, 2006, the Consulting  Agreement between the Company and Saddle Ranch
Productions,  Inc.  dated  January 1, 2006,  was  amended to set out the monthly
amount due for services rendered under the contract as well as the addition of a
commission for advertising to be sold.


                                       24
<PAGE>

Effective  July 25, 2006,  by written  action  completed on August 7, 2006,  the
Company's  shareholders  owning  an  aggregate  of  52.6%  of the  total  shares
outstanding of the Company, voted to approve the Medical Media Television,  Inc.
2006 Equity Incentive Plan with an effective date of May 1, 2006.

On September 1, 2006,  Robert  Cambridge and African  American  Medical  Network
executed a Settlement and Termination  Agreement wherein Mr. Cambridge  resigned
as President of African  American  Medical Network and his employment  agreement
was terminated.  The  resignation was not the result of a disagreement  with the
Company  on any  matter  relating  to the  Company's  operations,  policies,  or
practices.  Until  such  time  as the  Company's  Board  of  Directors  names  a
replacement, Mr. Cohen will oversee the network as its Chief Executive Officer.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

Critical Accounting Policies and Estimates

Our  financial  statements  have been  prepared in  accordance  with  accounting
principles  generally  accepted in the United States.  The  preparation of these
financial  statements  requires us to make  significant  estimates and judgments
that affect the reported amounts of assets, liabilities,  revenues, expenses and
related  disclosure  of  contingent  assets and  liabilities.  We  evaluate  our
estimates,  including  those related to  contingencies,  on an ongoing basis. We
base our estimates on  historical  experience  and on various other  assumptions
that are believed to be reasonable under the circumstances, the results of which
form the basis for  making  judgments  about the  carrying  values of assets and
liabilities that are not readily apparent from other sources. Actual results may
differ from these estimates under different assumptions or conditions.

Revenue Recognition

The Company generates revenue from three primary sources,  namely advertisers on
its  DVD  magazines  (the  "Advertisers"),  subscribers  to  its  networks  (the
"Subscribers"),  and the sale of our instructional  DVDs,  Welcome Home Your New
Friend and Welcome Home Your New Baby. With regard to  Advertisers,  the Company
recognizes revenue over the periods in which the advertisers' commercials appear
on  its  DVD  magazine.  With  regard  to  Subscribers,  revenue  is  recognized
proportionately  over the length of the subscription  agreement  entered into by
the  Subscribers.  With regard to Welcome  Home Your New Friend and Welcome Home
Your New Baby, revenue is recognized in the period the DVDs are shipped.

Results of Operations

The following  discussion  and analysis sets forth the major factors that affect
the Company's  results of operations  and financial  condition  reflected in the
unaudited  financial  statements for the three-month  period ended September 30,
2006 and the nine-month  period ended  September 30, 2006.  This  discussion and
analysis  should be read in conjunction  with the  information  contained in our
Annual  Report on Form  10-KSB for the  fiscal  year ended  December  31,  2005,
including the audited financial statements and footnotes included therein.

Results of Operations - Inception (October 2, 1989) to September 30, 2006

From  inception to September 30, 2006, we had losses  totaling  $8,692,933.  For
this period, our general and  administrative  costs totaled $4,198,207 or 54% of
total operating  expenses.  DVD production costs totaled $738,334 or 9% of total
operating  expenses,  and sales and marketing costs totaled $2,685,910 or 34% of
total operating  expenses.  The remainder of operating expense is represented by
depreciation  and  amortization  that totaled  $220,383 or 3% of total operating
expenses.


                                       25
<PAGE>

Results of Operations - Comparison of Nine Months Ending  September 30, 2006 and
2005

For the  nine-month  period ending  September  30, 2006, we had losses  totaling
$2,155,673,  compared to losses of $1,301,669 for the same period in 2005.  This
is an increase of $854,004.  During the nine-month  period ending  September 30,
2006, our general and administration costs totaled $929,547 compared to $586,417
for the same period in 2005,  which is primarily a result of: (i) costs  related
to our registration  statement on Form SB-2 filed during the first quarter, (ii)
placement fees related to the Quiros November Note and the CapitalSmart  funding
during  the first  quarter,  and (iii)  administrative  expenses  related to the
operation of African American Medical Network that we acquired in November 2005.
Our DVD production  costs totaled  $214,268 for the period ending  September 30,
2006,  compared to  $109,570  for the same  period in 2005.  This  increase is a
result of additional  production  efforts  related to African  American  Medical
Network.  Our sales and  marketing  costs  totaled  $854,224 for the nine months
ending  September  30,  2006,  compared to $351,437 for the same period in 2005.
This increase is a result of increased  sales and marketing  efforts  related to
PetCARE TV and the addition of African American  Medical  Network.  Depreciation
and  amortization  costs totaled $64,645 for the nine months ended September 30,
2006, which includes  amortization of certain  intangible assets acquired in the
acquisition of African American Medical Network.

Results of Operations - Comparison of Three Months Ending September 30, 2006 and
2005

For the  three-month  period ending  September 30, 2006, we had losses  totaling
$677,513, compared to losses of $336,789 for the same period in 2005. This is an
increase of $318,953.  During the three-month  period ending September 30, 2006,
our general and  administration  costs totaled $319,171 compared to $171,950 for
the same period in 2005, which is primarily a result of administrative  expenses
related to the operation of African American Medical Network that we acquired in
November 2005. Our DVD  production  costs totaled  $78,234 for the period ending
September  30,  2006,  compared  to $32,447  for the same  period in 2005.  This
increase  is a result  of  additional  production  efforts  related  to  African
American Medical Network. Our sales and marketing costs totaled $235,490 for the
three months ending September 30, 2006, compared to $160,410 for the same period
in 2005.  This  increase is a result of increased  sales and  marketing  efforts
related to PetCARE TV and the  addition  of African  American  Medical  Network.
Depreciation and  amortization  costs totaled $21,404 for the three months ended
September 30, 2006,  which includes  amortization of certain  intangible  assets
acquired in the acquisition of African American Medical Network.

Liquidity and Capital Resources

We have approximately  $4,426 of cash on hand as of November 17, 1006. We do not
believe that our cash on hand and  anticipated  revenues  will be  sufficient to
fund our operations through December 2006. Based on the current rate at which we
are using  capital and our debt  obligations  which  mature over the next twelve
months,  we  believe  that we will need to obtain  approximately  $4  million to
continue  our  operations  for the  next  twelve  months.  We do not  anticipate
significant  revenues from  advertising  sales or  subscription  sales until the
first  quarter of 2007. We have an aggregate of  approximately  $916,000 of debt
obligations  (including  accrued interest) which mature over the next six months
and an aggregate of  approximately  $2,348,000  of debt  obligations  (including
accrued  interest)  which  mature over the next  twelve  months.  The  foregoing
matters raise  substantial doubt about the ability of our Company to continue as
a going concern.  As such, we are actively  seeking  external sources to satisfy
our  capital  requirements.  We are  seeking  to raise this  additional  capital
through a public or private sale of debt or equity  securities,  debt financing,
or  short-term  loans.  We currently do not have any  financing  commitments  in
place,  and therefore,  cannot give any assurance that we will be able to secure
the additional cash or working capital we require to continue our operations. In
the event we are unsuccessful in our efforts to secure  additional  capital,  it
would have a material adverse effect on the Company's  results of operations and
financial condition.


                                       26
<PAGE>

The following is a summary of the material terms of our debt obligations.

On May 16,  2002,  we issued a  non-interest  bearing  promissory  note to James
Calaway, a shareholder and former director,  in the original principal amount of
$100,000 (the "Calaway Note").  At September 30, 2006, the principal balance due
on the Calaway Note was $61,000.

In  June  2002,  we  issued  the  following  shareholders  non-interest  bearing
promissory  notes  (the  "Hugo/Turner  Notes"),  all of which  remained  due and
payable at September 30, 2006:

      o     Daniel V. Hugo, a former officer/director, in the amount of $16,668;
      o     Robert and Janna Hugo, in the amount of $4,000; and
      o     Robert and Jamie Turner, in the amount of $3,332.

On May 6, 2005,  the Company  issued to Vicis  Capital  Master Fund  ("Vicis") a
Series B Convertible  Debenture  (the  "Debenture")  in the principal  amount of
$250,000,  and  related  Series D, Series E and Series F Common  Stock  Purchase
Warrants.  The Debenture has a term of 24 months and accrues  interest an annual
rate of fifteen  percent  (15%).  The Company has the option to pay  interest in
cash or in shares of its registered common stock at a ten percent (10%) discount
to the  market  price,  as  calculated  pursuant  to the  express  terms  of the
Debenture.  At  maturity,  Vicis may  convert the  Debenture  into shares of the
Company's  Common Stock at a price of $2.40 per share.  On October 19, 2005, the
conversion  price was reduced to $0.166  pursuant to the extension  terms of the
Series AA Convertible Debenture described in further detail below.

On November 16, 2005, the Company issued Series AA Convertible Debenture, Series
AA Common Stock Purchase Warrants,  and Series BB Common Stock Purchase Warrants
to Vicis.  Pursuant to the terms of the Series AA Convertible  Debenture,  Vicis
loaned the  Company an  aggregate  of  $412,000 at an annual rate of interest of
sixteen  percent  (16%).  The Series AA  Convertible  Debenture was cancelled on
August 11, 2006 and became part of a Secured  Convertible  Promissory Note dated
August 11, 2006 in the amount of $1,302,000.

On November  16,  2005,  the Company  issued a  Promissory  Note for $100,000 to
Laurence Wallace (the "Wallace  Promissory  Note") at an annual interest rate of
eight percent (8%). On the maturity date of the Wallace  Promissory  Note (April
17, 2006),  Wallace had the option to execute a debt conversion  agreement under
which the  principal  amount of the Wallace  Promissory  Note would convert into
100,000  units of the  Company's  securities,  each unit  consisting  of (i) two
shares of Medical Media's Common Stock (for an aggregate of 200,000 shares), and
(ii) one Common Stock  Purchase  Warrant to purchase an additional  share of the
Company's  Common Stock (for an aggregate of 100,000  warrants) with an exercise
price of $1.00 per share.  On October 12,  2006,  the  Company  and Mr.  Wallace
entered  into a letter of  extension  whereby the  maturity  date on the Wallace
Promissory Note was extended to April 15, 2007 (the  "Extension").  Terms of the
Extension include a payment of $5,000 on each of October 1, October 15, November
15, and December 15, 2006, and January 15,  February 15, and March 15, 2007, and
a final  payment  on April 15,  2007 of  $65,000  plus any  accrued  and  unpaid
interest.  Terms of the  Extension  canceled all  conversion  rights  previously
granted under the Wallace  Promissory Note and issued Wallace  three-year Common
Stock Purchase Warrants to purchase 100,000 shares of the Company's Common Stock
with a fixed  exercise  price of $0.17 per share.  As of November 17, 2006,  the
balance due is $100,000.


                                       27
<PAGE>

On November  16,  2005,  the Company  issued a  Promissory  Note for $200,000 to
Carmen Bernstein (the "Bernstein Promissory Note") at an annual interest rate of
ten  percent  (10%).  On the  maturity  date of the  Bernstein  Promissory  Note
(December  14,  2005),  Bernstein  had the option to  execute a debt  conversion
agreement  under which the  principal  amount of the Bernstein  Promissory  Note
would  convert  into  200,000  units  of the  Company's  securities,  each  unit
consisting of (i) one share of the  Company's  Common Stock (for an aggregate of
200,000  shares),  and (ii) one Common  Stock  Purchase  Warrant to  purchase an
additional  share of the  Company's  Common  Stock (for an  aggregate of 200,000
warrants)  with an exercise price of $2.00 per share.  The Bernstein  Promissory
Note was extended  indefinitely by mutual verbal  agreement.  As of November 17,
2006, the balance due is $145,000.

On  November  30,  2005,  the  Company  issued to William  H.  Quiros a 12-month
Convertible  Promissory  Note  ("November  Quiros  Note")  for  $1,000,000  with
interest  accruing  at the rate of twenty  percent  (20%) per annum,  compounded
semi-annually.  Interest was to be paid at the end of each  calendar  quarter in
either shares of Series C Zero Coupon  Preferred  Stock of the Company valued at
$1.00 per share,  or cash,  at the option of  Quiros.  The Series C Zero  Coupon
Preferred  Stock would convert into shares of the Company's  Common Stock on the
maturity date of the November Quiros Note at a ten percent (10%) discount to the
then-current market price based on the average closing price for the twenty (20)
days  immediately  preceding  the  conversion.  On December 31, 2005 the Company
issued 8,627 shares of its Series C Zero Coupon  Preferred  Stock as payment for
$8,627  interest  accrued  through  December  31,  2005.  The 8,627  shares  are
convertible into 9,586 shares of the Company's Common Stock. At maturity, Quiros
had the option to convert the  November  Quiros  Note into  Common  Stock of the
Company at a fixed  conversion  price of $.40 per share. The Company also issued
Quiros five-year Common Stock Purchase Warrants ("Quiros  Warrants") to purchase
an aggregate of 2,500,000  shares of common stock at a Fixed  Exercise  price of
$0.75 per share.  On July 28, 2006,  the Company and Quiros  agreed to amend the
terms of the November Quiros Note as follows: (i) the Maturity Date was extended
to November 30, 2008; (ii) the note would not be convertible  until the Maturity
Date;  (iii) the  Company  would  have the  option to repay the note at any time
prior to the Maturity Date; (iv) the conversion price on the note was changed to
an amount equal to a twenty  percent (20%) discount to the  then-current  market
price based on the average  closing  price for the twenty (20) days  immediately
preceding  the  conversion,  but in no event less than  $0.166  per  share;  (v)
quarterly  interest  payments  on the note would be applied  toward the  balance
remaining  unpaid  under the March Quiros Note (as  described  below) until such
time as the entire $450,000 under the March Quiros Note has been received by the
Company,  at which time all future interest will accrue, but will not become due
and payable  until the maturity  date;  and (vi)  certain  price  ratchets  were
deleted.  The November Quiros Warrants were also amended to delete certain price
ratchets.  The November Quiros Note and the  accompanying  Common Stock Purchase
Warrants are not  convertible  or exercisable  such that Quiros'  overall Common
Stock ownership position in the Company exceeds 4.99%;  provided,  however, that
upon Quiros  providing the Company with  sixty-one (61) days notice (the "Waiver
Notice") that he would like to waive this  restriction with regard to any or all
shares of Common Stock issuable upon exercise of the  conversion  feature of the
November Quiros Note, this restriction will be of no force or effect with regard
to all or a portion of the November Quiros Note referenced in the Waiver Notice,
and provided  further that this provision shall be of no further force or effect
during the sixty-one (61) days immediately  preceding the expiration of the term
of the November Quiros Note.


                                       28
<PAGE>

On January 27, 2006,  the Company and  CapitalSmart,  LLC, a California  limited
liability company, ("CSmart") entered into a Note Purchase Agreement pursuant to
which  CSmart  agreed to loan the Company an  aggregate  of  $1,000,000  through
installments  of $250,000 on February  15, 2006 and  $750,000 on March 31, 2006.
The Note Purchase Agreement provided that the Company issue Csmart a convertible
promissory  note in the  original  aggregate  face  amount  of  $1,000,000  (the
"CapitalSmart  Note") and five-year  Common Stock Purchase  Warrants to purchase
2,500,000  shares of the  Company's  Common Stock (the "CSmart  Warrants")  at a
Fixed Exercise  Price of $0.75 per share.  The Company issued the CSmart Note on
February 15, 2006 and issued  CSmart  625,000  Warrants.  The CSmart Note was to
mature twelve months from the date of issuance (the "Maturity Date") and accrued
interest at a rate of 20%  (compounded  semi-annually).  Interest was payable at
the end of each  quarter  in either (i)  shares of the  Company's  Series C Zero
Coupon  Preferred Stock valued a $1.00 per share, or (ii) cash, at the option of
CSmart.  The first interest  payment due on March 31, 2006 of $6,438 was paid on
April 1, 2006 in cash.  On the Maturity  Date,  CSmart had the option to convert
the CSmart Note into shares of the Company's  Common Stock at a fixed conversion
price of $0.40 per share.  As of July 28,  2006,  CSmart had loaned the  Company
$624,580.50  and CSmart and the Company agreed to cancel the Csmart Note and the
outstanding  625,000  CSmart  Warrants,  and to issue in lieu thereof,  separate
replacement  convertible  promissory  notes and  warrants to the  principals  of
CSmart or to entities  controlled  by the  principals  of CSmart.  In accordance
therewith,  four convertible promissory notes in an aggregate amount equal to $1
million were issued to: Softrev Partners, Inc. for $250,000, Gilbert B. Ross for
$200,000,  William H. Quiros for  $450,000,  and Steven Port for  $100,000.  The
notes,  described  in  detail  herein,  were  issued  on July 28,  2006  with an
effective date as to when each principal  contributed funds to the Company to be
applied toward the CSmart Note balance.

On February 15, 2006, the Company issued a Convertible Promissory Note to Steven
J. Port for  $100,000  (the  "February  Port Note") and  five-year  Common Stock
Purchase  Warrants to purchase 250,000 shares of the Company's Common Stock at a
Fixed  Exercise Price of $0.75 per share (the  "February  Port  Warrants").  The
February Port Note was issued as a partial  replacement  for the CSmart Note for
$1,000,000  described  above.  The February  Port Note will mature twelve months
from the date of issuance (the "Maturity Date") and accrues interest at the rate
of 20% compounded semi-annually. At the option of Port, interest will be paid at
the end of each  quarter  in either (i)  shares of the  Company's  Series C Zero
Coupon  Preferred Stock valued a $1.00 per share, or (ii) cash. With the consent
of both the  Company and Port,  the  February  Port Note may be extended  for an
additional 12 months with the terms of the interest payments remaining the same.
The Port Note is not convertible  until the Maturity Date. On the Maturity Date,
Port has the  option to  convert  the  February  Port  Note  into  shares of the
Company's  Common  Stock at a price equal to forty cents  ($0.40),  or an amount
equal to a twenty percent (20%) discount to the then-current  market price based
on the average closing price for the twenty (20) days immediately  preceding the
conversion, with the exception that the Conversion Price shall not be lower than
$0.166.

On February  16,  2006,  the Company  issued a  Convertible  Promissory  Note to
Gilbert B. Ross for  $200,000  (the  "Ross  Note") and  five-year  Common  Stock
Purchase  Warrants to purchase 500,000 shares of the Company's Common Stock at a
Fixed Exercise Price of $0.75 per share (the "Ross Warrants"). The Ross Note was
issued as a partial  replacement  for the CSmart Note for  $1,000,000  described
above.  The Ross Note will mature  three  years from the date of  issuance  (the
"Maturity  Date") and accrues  interest at the rate of twenty  percent (20%) per
annum. Interest accrues but is not due and payable until the Maturity Date. With
the consent of both the Company and Ross,  the Ross Note may be extended  for an
additional  12-month term, with the terms of the interest payments remaining the
same. The Ross Note is not convertible  until the Maturity Date. On the Maturity
Date,  Ross has the option to convert the Ross Note into shares of the Company's
Common  Stock  at a price  equal  to a  twenty  percent  (20%)  discount  to the
then-current market price based on the average closing price for the twenty (20)
days immediately preceding the conversion,  but in no event shall the Conversion
Price be less than $0.166 per share.


                                       29
<PAGE>

On March 31, 2006, the Company issued a Convertible  Promissory  Note to William
H. Quiros for $450,000 (the "March  Quiros Note") and agreed to issue  five-year
Common Stock  Purchase  Warrants to purchase  1,125,000  shares of the Company's
Common  Stock at a Fixed  Exercise  Price of $0.75 per share (the "March  Quiros
Warrants").  The March Quiros Note was issued as a partial  replacement  for the
CSmart Note for $1,000,000 described above. Per the terms of the November Quiros
Note, as amended,  quarterly interest payments on the November Quiros Note would
be applied toward the balance remaining unpaid under the March Quiros Note until
such time as the entire  $450,000  under the March Quiros Note has been received
by the Company.  Additionally,  quarterly  interest payments on the March Quiros
Note would be applied toward the balance remaining unpaid under the March Quiros
Note until such time as the entire $450,000 under the March Quiros Note has been
received by the Company, at which time all future interest will accrue, but will
not become due and payable until the maturity  date.  The March Quiros Note will
mature three years from the date of issuance (the  "Maturity  Date") and accrues
interest at a rate of twenty  percent (20%) per annum.  Interest  accrues but is
not due and  payable  until the  Maturity  Date.  With the  consent  of both the
Company and Quiros,  the March  Quiros  Note may be extended  for an  additional
12-month term, with the terms of the interest  payments  remaining the same. The
March Quiros Note is not  convertible  until the Maturity  Date. On the Maturity
Date,  Quiros has the option to convert the March Quiros Note into shares of the
Company's  Common Stock at a price equal to a twenty  percent (20%)  discount to
the then-current  market price based on the average closing price for the twenty
(20)  days  immediately  preceding  the  conversion,  but in no event  shall the
Conversion  Price be less than $0.166 per share.  As of September 30, 2006,  Mr.
Quiros had loaned the Company $128,751 under the March Quiros Note.

On March 31, 2006, the Company issued a Convertible Promissory Note to Elaine G.
Edinburg for $10,000 (the "Edinburg  Note") and five-year  Common Stock Purchase
Warrants to purchase  25,000  shares of the  Company's  Common  Stock at a Fixed
Exercise Price of $0.75 per share (the "Edinburg  Warrants").  The Edinburg Note
matures  twelve  months  from the date of  issuance  (the  "Maturity  Date") and
accrues interest at a rate of twenty percent (20%) compounded semi-annually.  At
the  option of  Edinburg,  interest  will be paid at the end of each  quarter in
either (i) shares of the Company's Series C Zero Coupon Preferred Stock valued a
$1.00 per share, or (ii) cash. On the Maturity Date,  Edinburg had the option to
convert the Edinburg Note into shares of the  Company's  Common Stock at a Fixed
Conversion  Price of $0.40 per share.  With the  consent of both the Company and
Edinburg, the Edinburg Note may be extended for an additional twelve (12) months
with the terms of the interest  payments  remaining  the same. On June 20, 2006,
Edinburg and the Company agreed to amend the Edinburg Note and Edinburg Warrants
as follows:  (i) the conversion price was changed to the Investor's option of an
amount equal to forty cents ($0.40) or an amount equal to a twenty percent (20%)
discount to the then-current market price based on the average closing price for
the twenty (20) days  immediately  preceding the conversion,  with the exception
that the  Conversion  Price  shall  not be lower  than  $0.166;  and (ii)  price
ratchets were deleted.  On September 30, 2006,  the Company issued 998 shares of
its Series C Zero Coupon  Preferred  Stock as payment for $998 interest  accrued
through September 30, 2006.

On April 1, 2006, the Company issued a Convertible  Promissory Note to Steven J.
Port for $125,000  made in  installments  (the "April Port Note") and  five-year
Common  Stock  Purchase  Warrants to purchase  312,500  shares of the  Company's
Common  Stock at a Fixed  Exercise  Price of $0.75 per share  (the  "April  Port
Warrants"). The original maturity date of the April Port Note was April 30, 2006
and interest  accrues at the rate of twenty  percent  (20%) per annum.  Interest
accrues, but is not due and payable until the Maturity Date. The April Port Note
automatically  extends to the end of each  succeeding  month  until such time as
Port  provides a 15-day  written  notice to the Company that the April Port Note
may no longer be automatically  extended.  The terms of interest will remain the
same throughout the automatic  extension periods. On the Maturity Date, Port has
the option to convert  the April Port Note into shares of the  Company's  Common
Stock at a price equal to an amount equal to forty cents  ($0.40),  or an amount
equal to a twenty percent (20%) discount to the then-current  market price based
on the average closing price for the twenty (20) days immediately  preceding the
conversion, with the exception that the Conversion Price shall not be lower than
$0.166.  On September 30, 2006, the Company issued 11,644 shares of its Series C
Zero Coupon  Preferred  Stock as payment for $11,644  interest  accrued  through
September 30, 2006.


                                       30
<PAGE>

On April 16, 2006, the Company issued a Convertible  Promissory  Note to Softrev
Partners,  Inc. for $250,000  (the "Softrev  Note") and  five-year  Common Stock
Purchase  Warrants to purchase 625,000 shares of the Company's Common Stock at a
Fixed  Exercise Price of $0.75 per share (the "Softrev  Warrants").  The Softrev
Note was  issued as a partial  replacement  for the CSmart  Note for  $1,000,000
described  above. The Softrev Note matures three years from the date of issuance
(the "Maturity Date") and accrues interest at a rate of twenty percent (20%) per
annum. Interest accrues but is not due and payable until the Maturity Date. With
the consent of both the Company and  Softrev,  the Softrev  Note may be extended
for an  additional  12-month  term,  with  the  terms of the  interest  payments
remaining the same. The Softrev Note shall not be convertible until the Maturity
Date. On the Maturity  Date,  Softrev has the option to convert the Softrev Note
into shares of the Company's  Common Stock at a price equal to a twenty  percent
(20%)  discount to the  then-current  market price based on the average  closing
price for the twenty (20) days immediately  preceding the conversion,  but in no
event shall the Conversion Price be less than $0.166 per share.

On June 1,  2006,  the  Company  issued a Secured  Promissory  Note to Vicis for
$50,000  ("Vicis  June 1 Secured  Note").  The Vicis June 1 Secured  Note was to
mature on December 31, 2006 and accrued  interest at a rate of eighteen  percent
(18%) per annum.  The Vicis  June 1 Secured  Note was  secured  by all  accounts
receivable due from Butler Animal Health Supply after June 1, 2006, or any other
money due the Company from any and all other  sources.  The Vicis June 1 Secured
Note could be prepaid in whole or in part at any time, with a prepayment penalty
of $5,492.25.  On August 11, 2006,  Vicis  surrendered  the Vicis June 1 Secured
Note  as  partial   consideration  for  the  Company's  issuance  of  a  Secured
Convertible Promissory Note in the principal amount of $1,302,000.

On June 30,  2006,  the Company  issued a Secured  Promissory  Note to Vicis for
$50,000  ("Vicis June 30 Secured  Note").  The Vicis June 30 Secured Note was to
mature on January 31, 2007 and  accrued  interest at a rate of eighteen  percent
(18%) per  annum.  The Vicis June 30 Secured  Note was  secured by all  accounts
receivable  due from Butler  Animal  Health  Supply after June 30, 2006,  or any
other money due the Company  from any and all other  sources.  The Vicis June 30
Secured Note could be prepaid in whole or in part at any time, with a prepayment
penalty of $5,492.25.  On August 11, 2006,  Vicis  surrendered the Vicis June 30
Secured Note as partial  consideration  for the Company's  issuance of a Secured
Convertible Promissory Note in the principal amount of $1,302,000. On August 11,
2006,  the  Company  issued a 10%  Secured  Convertible  Promissory  Note in the
principal  amount of $1,302,000 (the "Note") to Vicis pursuant to the terms of a
Note Purchase  Agreement.  As  consideration  for the Note,  Vicis (a) delivered
$790,000 in cash (the "Cash  Payment");  (b) surrendered two secured  promissory
notes  issued  by the  Company  to Vicis  on June 1,  2006,  and June 30,  2006,
respectively,  each in the principal amount of $50,000 (collectively,  the "June
Notes");  and (c)  surrendered a Series AA  Convertible  Debenture  No.  05-0719
issued by the  Company to Vicis on July 19,  2005,  in the  principal  amount of
$412,000  (the  "Debenture").  At any time while the Note  remains  outstanding,
Vicis may convert the outstanding  principal  balance and any accrued but unpaid
interest on the Note into shares of the Company's Common Stock, par value $.0005
per share, at a conversion price of $.166 per share (the  "Conversion  Shares").
The  principal  balance of the Note is due in one lump sum payment on August 10,
2007 (the "Maturity Date"), unless earlier converted. Interest on such principal
(or any balance thereof outstanding from time to time) accrued at an annual rate
of interest  of ten  percent  (10%) and was  payable on the  Maturity  Date.  As
security for the  Company's  obligations  under the Purchase  Agreement  and the
Note,   the  Company   pledged  all  of  the  capital  stock  of  the  Company's
subsidiaries,  PetCARE TV,  African  American  Medical  Network,  and KidCARE TV
(collectively the  "Subsidiaries"),  pursuant to the terms of a Stock Pledge and
Escrow Agreement,  dated August 11, 2006. Repayment of the Note is guaranteed by
the Subsidiaries and is also secured by a blanket lien encumbering the assets of
the Company and the  Subsidiaries.  As an  inducement  for Vicis to purchase the
Note,  Philip M. Cohen,  President and Chief  Executive  Officer of the Company,
agreed to amend his employment agreement to include a three (3) year non-compete
clause.


                                       31
<PAGE>

From  inception  through  September  30, 2006, we incurred  interest  expense of
$1,257,312.   This  amount  includes  accrued  interest  totaling  approximately
$187,425.  It also includes (i) a $250,000  non-cash payment of interest related
to the Victus  February Note (in May 2004, we issued 11,905 shares of our Common
Stock at $21.00 per share and 23,810 Common Stock  Purchase  Warrants in lieu of
$250,000 in interest due),  (ii) a $307,044  payment of interest  related to the
Edge Notes (which was paid  through the  issuance of 307,044  shares of Series A
Zero Coupon  Preferred  Stock),  (iii) a $312,329 payment of interest related to
the Vicis  Debentures  and Maltzer  Note (which was paid through the issuance of
312,239  shares of Series B Zero Coupon  Preferred  Stock),  and (iv) $21,269 in
payment of  interest  related  to certain  notes  which  were paid  through  the
issuance of 21,269 shares of Series C Zero Coupon Preferred  Stock),  and (v) an
additional $179,245 in interest paid.

Item 3.     Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report,  the Company  carried out an
evaluation,  under the supervision and with the  participation  of the Company's
Principal Executive Officer and Principal Financial Officer of the effectiveness
of the design and operation of the Company's disclosure controls and procedures.
The Company's  disclosure  controls and  procedures  are designed to ensure that
information  required  to be  disclosed  by us in the  reports we file or submit
under the Exchange Act is recorded,  processed,  summarized and reported, within
the time periods specified in the SEC's rules and forms. The Company's Principal
Executive  Officer and  Principal  Financial  Officer  have  concluded  that the
Company's  disclosure  controls and procedures  are, in fact,  effective at this
reasonable assurance level as of the period covered.

Changes in Internal Controls over Financial Reporting

In connection with the evaluation of the Company's  internal controls during the
Company's  quarter ended September 30, 2006, the Company's  Principal  Executive
Officer  and  Principal  Financial  Officer  have  determined  that there are no
changes to the Company's  internal  controls over financial  reporting that have
materially  affected,  or  are  reasonably  likely  to  materially  effect,  the
Company's internal controls over financial reporting.

PART II - OTHER INFORMATION

Item 1.     Legal Proceedings.

None.

Item 2.     Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

On October 12, 2006, the Company issued Laurence Wallace three-year Common Stock
Purchase  Warrants to purchase 100,000 shares of the Company's Common Stock with
a fixed  exercise price of $0.17 per share.  The Common Stock Purchase  Warrants
were  issued  pursuant  to a letter of  extension  whereby  the  Company and Mr.
Wallace  agreed to extend the  maturity  date of a  promissory  note held by Mr.
Wallace from April 17, 2006 to April 15, 2007.  The issuance of the Common Stock
Purchase  Warrants  was  exempt  from  the  registration   requirements  of  the
Securities Act of 1933, as amended, pursuant to Section 4(2).


                                       32
<PAGE>

Issuer Purchases of Equity Securities

The Company did not repurchase any equity  securities  during the fiscal quarter
ended September 30, 2006.

Item 3.     Defaults upon Senior Securities.

On November  16,  2005,  the Company  issued a  Promissory  Note for $200,000 to
Carmen Bernstein (the "Bernstein  Promissory  Note").  The Bernstein  Promissory
Note  accrues  interest  at an annual  rate of ten  percent  (10%).  The  entire
principal  balance plus any accrued but unpaid  interest was due on December 14,
2005. As of the date of this filing,  the amounts due  thereunder  have not been
repaid, although it has been extended indefinitely by mutual verbal agreement.

On November  16,  2005,  the Company  issued a  Promissory  Note for $100,000 to
Laurence Wallace (the "Wallace  Promissory  Note") at an annual interest rate of
eight  percent (8%). On October 12, 2006,  the Company and Mr.  Wallace  entered
into a letter of extension  whereby the maturity date on the Wallace  Promissory
Note was extended to April 15, 2007 (the  "Extension").  Terms of the  Extension
include a payment of $5,000 on each of October 1,  October 15,  November 15, and
December 15, 2006, and January 15,  February 15, and March 15, 2007, and a final
payment on April 15, 2007 of $65,000 plus any accrued and unpaid interest. As of
the date of this filing,  the first three payments  required to be made pursuant
to the Extension have not been made.

Item 4.     Submission of Matters to a Vote of Security Holders.

None.

Item 5.     Other Information.

None.


                  (Remainder of page left intentionally blank.)


                                       33
<PAGE>

Item 6.     Exhibits.

<TABLE>
<CAPTION>
---------- ----------------------- --------------------------------------------------------------------------------------------
Exh. No.   Date of Document                                       Description of Document
---------- ----------------------- --------------------------------------------------------------------------------------------
<C>        <C>                     <C>
3.0        January 2, 1997         Amended and Restated Articles of Incorporation of Transition Lifestyle Consultants, Inc. (1)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.1        June 12, 2002           Articles of Amendment to the Articles of Incorporation (name change to PetCARE Television
                                   Network, Inc.) (1)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.2        August 2, 2002          Articles of Amendment to the Articles of Incorporation (Series A Convertible Preferred
                                   Stock). (1)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.3        November 12, 2003       Articles of Amendment to the Articles of Incorporation (Series B Convertible Preferred
                                   Stock). (2)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.4        March 30, 2004          Articles of Amendment to the Articles of Incorporation (amend Series A Convertible
                                   Preferred Stock). (2)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.5        June 10, 2004           Articles of Amendment to the Articles of Incorporation (amend Series B Convertible
                                   Preferred Stock). (3)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.6        March 25, 2005          Articles of Amendment to the Articles of Incorporation (increase in authorized stock). (4)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.7        April 21, 2005          Articles of Amendment to the Articles of Incorporation (name change to Medical Media
                                   Television, Inc.). (4)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.8        July 14, 2005           Articles of Amendment to the Articles of Incorporation (Series A Zero Coupon Preferred;
                                   Series B Zero Coupon Preferred). (5)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.9        November 16, 2005       Articles of Merger. (6)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.10       December 22, 2005       Articles of Amendment to the Articles of Incorporation (Series C Zero Coupon Preferred
                                   Stock). (7)
---------- ----------------------- --------------------------------------------------------------------------------------------
3.11       N/A                     Bylaws of PetCARE Television Network, Inc. (1)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.01      July 25, 2006           Amended Consulting Agreement between the Company and Saddle Ranch Productions, Inc. (8)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.02      July 26, 2006           Common Stock Purchase Warrant from the Company to William H. Quiros (8)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.03      August 11, 2006         Note Purchase Agreement by and between the Company and Vicis Capital Master Fund for a
                                   $1,302,000 loan (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.04      August 11, 2006         10% Secured Convertible Promissory Note from the Company to Vicis Capital Master Fund for
                                   $1,302,000 (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.05      August 11, 2006         Stock Pledge and Escrow Agreement by and between the Company and Vicis Capital Master
                                   Fund (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.06      August 11, 2006         Registration Rights Agreement by and between the Company and Vicis Capital Master Fund (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.07      August 11, 2006         Security Agreement by and between the Company and Vicis Capital Master Fund (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.08      August 11, 2006         Guaranty Agreement by and between PetCARE Television Network, Inc. and Vicis Capital
                                   Master Fund (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.09      August 11, 2006         Guaranty Agreement by and between African American Medical Network, Inc. and Vicis Capital
                                   Master Fund (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.10      August 11, 2006         Guaranty Agreement by and between KidCARE Medical Television Network, Inc. and Vicis
                                   Capital Master Fund (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.11      August 11, 2006         Guarantor Security Agreement by and between PetCARE Television Network, Inc. and Vicis
                                   Capital Master Fund (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.12      August 11, 2006         Guarantor Security Agreement by and between African American Medical Network, Inc. and
                                   Vicis Capital Master Fund (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.13      August 11, 2006         Guarantor Security Agreement by and between KidCARE Medical Television Network, Inc. and
                                   Vicis Capital Master Fund (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.14      August 11, 2006         Second Amended Employment Agreement between the Company and Philip M. Cohen (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.15      August 11, 2006         Resignation letter of Randall Maxey (9)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.16      September 1, 2006       Settlement and Termination Agreement between African American Medical Network, Inc. and
                                   Robert Cambridge (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
10.17      September 29, 2006      Extension agreement between the Company and Laurence Wallace (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
</TABLE>

                                       34
<PAGE>

<TABLE>
<CAPTION>
---------- ----------------------- --------------------------------------------------------------------------------------------
Exh. No.   Date of Document                                       Description of Document
---------- ----------------------- --------------------------------------------------------------------------------------------
<C>        <C>                     <C>
10.18      September 29, 2006      Common Stock Purchase Warrant to Laurence Wallace (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
23.1       November 17, 2006       Consent of Independent Public Accounting Firm (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
31.1       November 17, 2006       Certification of Chief Executive Officer of Periodic Report pursuant to Rule 13a-14a and
                                   Rule 14d-14(a). (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
31.2       November 17, 2006       Certification of Principal Financial Officer of Periodic Report pursuant to Rule 13a-14a
                                   and Rule 15d-14(a). (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
32.1       November 17, 2006       Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
32.2       November 17, 2006       Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350. (*)
---------- ----------------------- --------------------------------------------------------------------------------------------
</TABLE>

      (1)   Previously filed with  Registration  Statement on Form SB-2 filed on
            November 5, 2003.
      (2)   Previously  filed with Form 10-KSB for year ended  December 31, 2003
            filed on March 26, 2004.
      (3)   Previously  filed with Form  10-QSB for period  ended June 30,  2004
            filed on August 18, 2004.
      (4)   Previously  filed with Form  10-QSB for period  ended March 31, 2005
            filed on May 16, 2005.
      (5)   Previously  filed with Form  10-QSB for period  ended June 30,  2005
            filed on September 9, 2005.
      (6)   Previously  filed with Form 10-QSB for period  ended  September  30,
            2005 filed on November 21, 2005.
      (7)   Previously filed with Form SB-2 filed on February 10, 2006.
      (8)   Previously  filed with Form  10-QSB for period  ended June 30,  2006
            filed on August 21, 2006.
      (9)   Previously filed with Form 8-K dated August 11, 2006 filed on August
            17, 2006.
      (*)   Filed herewith.

                  (Remainder of page left intentionally blank.)


                                       35
<PAGE>

                                   SIGNATURES

      In accordance  with the  requirements  of the Exchange Act, the Registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.



Dated:   November 17, 2006            MEDICAL MEDIA TELEVISION, INC.



                                      By: /s/ Philip M. Cohen
                                          --------------------------------------
                                              Philip M. Cohen, President
                                              and Chief Executive Officer


                                      By: /s/ Donald R. Mastropietro
                                          --------------------------------------
                                          Donald R. Mastropietro, Vice President
                                          Finance and Chief Financial Officer


                                       36